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Complex neuronal circuitries such as those present in the mammalian cerebral cortex 
have evolved as balanced networks of excitatory and inhibitory neurons. Although the 
establishment of appropriate numbers for these cells is essential for brain function and 
behaviour, our understanding of this fundamental process is very fragmentary. Here we 
show that interneuron cell survival in mice depends on the activity of pyramidal cells 
during a critical window of postnatal development, in which excitatory synaptic input to 
individual interneurons predicts their outcome. Pyramidal cells regulate interneuron 
survival through the negative modulation of PTEN signalling, which effectively drives 
interneuron cell death during this period. Taken together, our findings indicate that 
activity-dependent mechanisms dynamically adjust the number of inhibitory cells in 
nascent local cortical circuits, ultimately establishing the appropriate proportions of 
excitatory and inhibitory neurons in the cerebral cortex. 
In the adult neocortex, approximately one in six neurons are inhibitory gamma-aminobutyric 
acid-containing (GABAergic) interneurons1,2, and this ratio is relatively stable across cortical 
regions and species regardless of total neuronal numbers3-6. The cellular balance between 
excitation and inhibition is critical for brain function and is likely disrupted in a number of 
neuropsychiatric conditions7-9. However, the mechanisms regulating the establishment of 
appropriate numbers of excitatory and inhibitory neurons in the cerebral cortex remain largely 
unknown. 
Programmed cell death, also known as apoptosis, is an essential mechanism that sculpts the 
central and peripheral nervous systems during development10-12. The death of developing 
neurons is mediated by an evolutionarily conserved signalling pathway that involves the pro-
apoptotic Bcl2 family members Bax and Bak13. Previous studies have shown that both cortical 
pyramidal cells and GABAergic interneurons undergo extensive cell death during postnatal 
development14,15, which suggests that apoptosis may contribute to the establishment of balanced 
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networks of excitatory and inhibitory neurons in the cerebral cortex. However, the temporal 
relationship and interdependency of the programmed cell death periods for both populations of 
neurons have not been explored in detail. 
Concatenated waves of neuronal death 
To determine the developmental sequence that establishes the final ratio of excitatory and 
inhibitory neurons in the cerebral cortex, we estimated the absolute numbers and relative 
proportions of pyramidal cells and GABAergic interneurons at different postnatal stages of 
development using stereological methods in mouse strains in which specific classes of neurons 
are irreversibly labelled. We chose this method to estimate programmed cell death over the 
direct quantification of dying cells because classical apoptotic markers such as cleaved caspase-
3 have non-apoptotic roles in neurons16 and are only expressed very transiently (Extended Data 
Fig. 1a, b). We crossed NexCre/+ and Nkx2-1-Cre mice with appropriate reporter strains (see 
Methods) to identify pyramidal cells and GABAergic interneurons, respectively. Expression of 
Cre under the control of the Neurod6 locus in NexCre/+ mice labels all cortical excitatory neurons 
with the exception of Cajal-Retzius cells17. Nkx2-1-Cre mice specifically label interneurons 
derived from the medial ganglionic eminence (MGE) and preoptic area (POA), including the 
two largest groups of cortical GABAergic interneurons, Parvalbumin (PV+) and Somatostatin 
(SST+) expressing cells18. 
We observed that the total number of excitatory neurons in the neocortex decreases (~12%) 
between postnatal day (P) 2 and P5, and then remains stable into adulthood (Fig. 1a, b, e). The 
reduction in excitatory neurons affects all layers of the neocortex and not only subplate cells 
(Extended Data Fig. 1c–e), which are known to undergo programmed cell death during this 
period19. By contrast, we found that the number of interneurons is steady until P5, drops 
extensively between P5 and P10 (~30%), and remains constant into adulthood (Fig. 1c–e). 
Interneuron cell loss follows the normal maturation sequence of MGE/POA interneurons20, with 
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deep layer interneurons adjusting their numbers ahead of superficial layer interneurons (Fig. 
1f). These results revealed that consecutive waves of programmed cell death adjust the final 
ratio of excitatory and inhibitory neurons in the developing cerebral cortex. 
Interneuron activity predicts cell death 
Our results indicated that the adjustment of interneuron numbers is preceded by a wave of 
pyramidal cell death, which suggest that these two processes might be directly linked. Since 
previous work has shown that neuronal activity and apoptosis rates are inversely correlated in 
the developing brain21-23, we hypothesised that pyramidal cells may impact interneuron survival 
by increasing the activity of the cells they connect to. We began testing this idea by monitoring 
the activity of MGE/POA interneurons in the superficial layers of the barrel cortex (S1BF) 
during the period of interneuron cell death. To this end, we generated mice expressing the 
fluorescent reporter tdTomato and the genetically encoded calcium sensor GCaMP6s in 
MGE/POA interneurons (Nkx2-1-Cre;RCLtdT/GCaMP6s)24 and performed long-term Ca2+ imaging 
in the same interneurons from layer 2/3 S1BF of awake, head-restrained pups (Fig. 2a). To 
select the most appropriate time for these experiments, we estimated interneuron cell death in 
S1BF during postnatal development and found comparable dynamics to the rest of the 
neocortex (Extended Data Fig. 2). For layer 2/3, we observed the most prominent decrease in 
the number of MGE/POA interneurons between P7 and P8 (Fig. 2b). 
We first established our ability to identify surviving interneurons at both times. As expected, 
we observed that the majority of tdTomato+ interneurons in a region of interest (ROI) were 
present in the same location the following day (Fig. 2c). However, we also observed that a 
fraction of tdTomato+ interneurons disappeared between P7 and P8 (Fig. 2c). Since MGE/POA 
interneurons have ceased migration at the end of the first postnatal week25, these observations 
are consistent with the idea that the cells disappearing between P7 and P8 have undergone 
apoptosis.  
 5 
We next wondered whether neural activity at P7 in interneurons that die by P8 was different 
from that of cells that lived past P8. Analysis of calcium event rates (events/min) at P7 indicated 
that interneurons that died at P8 exhibited significantly fewer calcium events than neurons that 
lived past P8 (Fig. 2d, e). We next analysed whether P7 event rates could discriminate between 
neurons that die at P8 and neurons that live beyond this day. Receiver-operating characteristic 
(ROC) analysis revealed that event rate at P7 performs significantly better than chance in 
discriminating between these two populations (Fig. 2f). These results suggested that 
interneurons with relatively low levels of activity immediately before the period of interneuron 
cell death have an increased probability to undergo apoptosis26,27.  
Pyramidal cells regulate interneuron death 
The previous experiments led us to hypothesise that interneurons receiving abundant or 
particularly strong inputs during the period of interneuron cell death would have increased 
chances to survive. Since PV+ and SST+ interneurons receive most of their inputs from local 
pyramidal cells during the first postnatal week28, we reasoned that modifying the activity of 
cortical excitatory neurons during the period of interneuron cell death would influence 
interneuron survival. To test this idea, we transiently modified the activity of pyramidal cells 
using a chemogenetic approach based on Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) that induce neuronal activation or inhibition29. We injected the 
primary somatosensory cortex (S1) of P0 NexCre/+ (pyramidal cell-specific) mice with the adeno-
associated virus (AAV) encoding mutant G protein-coupled receptors that induce neuronal 
activation (hM3Dq) or inhibition (hM4Di) following administration of the pharmacologically 
inert molecule clozapine-N-oxide (CNO) (Fig. 3a). We then injected pups with CNO twice 
daily between P5 and P8, and examined the distribution of interneurons at P21 (Fig. 3a). We 
found that increasing the activity of pyramidal cells during the period of interneuron cell death 
prevents this process and leads to a significant increase in the density of PV+ and SST+ 
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interneurons at P21 compared to control mice (Fig. 3b–d). This effect was not due to activity-
dependent changes in the expression of PV or SST or in the density of pyramidal cells 
(Extended Data Fig. 3a, b). We also found that dampening the activity of pyramidal cells 
decreases the density of PV+ and SST+ interneurons at P21 compared to controls, which 
indicates that interneuron cell death can be bi-directionally modulated by modifying the activity 
of pyramidal cells (Fig. 3b–d). In both types of experiments, changes in the density of 
interneurons were homogenously distributed across layers containing PV+ and SST+ 
interneurons (Extended Data Fig. 3c, d). CNO administration did not cause a redistribution of 
interneurons from neocortical areas adjacent to the injection site (Extended Data Fig. 3e, f). 
Instead, we observed a prominent increase in the density of cleaved caspase-3 cells following 
inhibition of the activity of pyramidal cells during the normal period of interneuron cell death 
(Extended Data Fig. 4a–c). Importantly, control experiments revealed that CNO did not modify 
the density of PV or SST interneurons in pups not infected with AAV-expressing DREADDs 
(Extended Data Fig. 4d, e). Similarly, CNO administration between P10 and P13 in hM3Dq- 
and hM4Di-injected mice revealed no significant changes in the density of PV+ and SST+ 
interneurons at P21 (Extended Data Fig. 5). Altogether, these experiments demonstrated that 
pyramidal cells activity is an essential regulator of interneuron survival during the normal 
period of interneuron cell death.  
Interneurons match pyramidal cell numbers 
The previous experiments suggest that pyramidal cells ‘rescue’ appropriate numbers of cortical 
interneurons from programmed cell death through an activity-dependent mechanism. Based on 
this idea, we reasoned that modifying the number of pyramidal cells prior to the period of 
interneuron cell death should also influence the number of surviving interneurons. To test this 
hypothesis, we generated conditional mice in which pyramidal cells specifically lack Bak and 
Bax, whose combined function is critical for apoptosis30. As expected, we observed that the 
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number of excitatory neurons in the cerebral cortex of NexCre/+;Bak-/-;Baxfl/fl mutant mice does 
not decline between P2 and P21 (Extended Data Fig. 6). Consequently, NexCre/+;Bak-/-;Baxfl/fl 
mutant mice have approximately 12% more pyramidal cells than control animals (Fig. 1b and 
Extended Data Fig. 6).  
We next quantified PV+ and SST+ interneurons in S1 of control and NexCre/+;Bak-/-;Baxfl/fl 
mutant mice at P21. We found that the density of both PV+ and SST+ interneurons increases 
by roughly 30% in NexCre/+;Bak-/-;Baxfl/fl mutant mice compared to controls (Fig. 4a, c), which 
suggests that interneuron cell death is suppressed when pyramidal cell death is prevented. This 
increase is homogenously distributed across layers containing PV+ and SST+ interneurons 
(Extended Data Fig. 7a), and was also observed in other neocortical areas (Extended Data Fig. 
7c, d). To evaluate whether the increase in the number of PV+ and SST+ interneurons represents 
the entire population of cells that should have normally died through programmed cell death, 
we generated conditional mice lacking Bax and Bak in MGE/POA interneurons. We found that 
the density of PV+ and SST+ interneurons also increases by approximately 30% in Nkx2-1-
Cre;Bak-/-;Baxfl/fl mutant mice compared to controls (Fig. 4b, c). Indeed, fold changes for PV+ 
and SST+ interneurons were identical for NexCre/+;Bak-/-;Baxfl/fl and Nkx2-1-Cre;Bak-/-;Baxfl/fl 
mutant mice (Extended Data Fig. 7b). These results revealed that preventing pyramidal cell 
death is sufficient to abolish programmed cell death in MGE/POA interneurons, which 
reinforces the idea that excitatory input from pyramidal cells onto interneurons during early 
postnatal development is critical for establishing the appropriate ratio of excitatory and 
inhibitory cells in the cerebral cortex. 
PTEN regulates interneuron cell death 
We next investigated the molecular mechanisms through which pyramidal cell activity prevents 
programmed cell death in cortical interneurons. In the developing nervous system, the serine-
threonine kinase Akt is a critical mediator of neuronal survival31,32 that is antagonised by the 
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activity of the phosphatase and tensin homolog PTEN33,34. Consistent with this notion, we 
observed that the relative levels of activated Akt (P-Akt/Akt ratio) transiently increase in the 
neocortex during the period of interneuron cell death (Fig. 5a). Interestingly, PTEN levels are 
very heterogeneous among MGE/POA interneurons during the same period (Fig. 5b). PTEN 
levels are transiently elevated in sparse interneurons in deep and superficial layers of S1 and 
this increase is concurrent with the peak of interneuron cell death in these layers (Fig. 5c, d and 
Extended Data Fig. 8a, b). These observations led us to hypothesise that high PTEN levels 
during this period may drive interneurons towards cell death, and that pyramidal cells might 
influence this process by regulating PTEN in interneurons. 
To test this hypothesis, we generated mice in which we conditionally deleted Pten from 
postmitotic MGE interneurons35,36. We observed that Lhx6-Cre;Ptenfl/fl mutant mice have 
abnormally large jaws and reduced body weight compared to their littermates by P16, probably 
due to the embryonic expression of Lhx6 in the first branchial arch37, which prevented their 
analysis at later developmental stages. We nevertheless found that Pten conditional mutants 
have a significant increase in the density of PV and SST interneurons in S1 compared to control 
mice (Fig. 5e, f, g and Extended Data Fig. 8c, d), without changing their relative distribution 
across layers (Extended Data Fig. 8e). Since Lhx6-Cre drives recombination in endothelial cells 
in addition to MGE interneurons35, we examined whether a change in the organisation of 
neocortical blood vessels might contribute to increased survival of interneurons in conditional 
Pten mutants. We found that the density of blood vessels increases in conditional Pten mutants 
compared to controls (Extended Data Fig. 8c, d). However, this change does not affect the 
density of pyramidal cells (Extended Data Fig. 8c, d), which rules out an indirect effect of blood 
vessels on interneuron survival through an increase in pyramidal cell density. To discard a direct 
effect of blood vessels on interneuron survival, we carried out a second series of experiments 
using acute pharmacological inhibition of PTEN. We injected the PTEN inhibitor bpV(pic) 
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systemically at P7 and P8 in wild type mice and analysed blood vessel density in S1 at P10 
(Extended Data Fig. 9b, c). Mice injected with the PTEN inhibitor did not exhibit increased 
blood vessel coverage (Extended Data Fig. 9b, c). In contrast, transient PTEN inhibition during 
the period of interneuron cell death increased the density of MGE interneurons compared to 
control mice (Extended Data Fig. 9a, d, e). Mice injected with the PTEN inhibitor outside the 
normal window of interneuron programmed cell death showed similar densities of PV and SST 
interneurons than controls (Extended Data Fig. 9f–h). These results revealed that PTEN is most 
likely required cell-autonomously for interneuron apoptosis during the normal period of 
interneuron cell death. 
Finally, we examined whether pyramidal cell activity influences the survival of interneurons 
by non-cell autonomously regulating the expression of PTEN levels in these cells during the 
period of interneuron cell death. To this end, we carried out DREADDs experiments similar to 
those that led to an increased number of cortical interneurons following transient activation of 
pyramidal cells between P5 and P8 (Fig. 3), but here we analysed PTEN levels in cortical 
interneurons at P8 (Fig. 5h). We found that PTEN levels are significantly decreased in 
GABAergic interneurons following the activation of pyramidal cells (Fig. 5i, j). These results 
strongly suggested that pyramidal cells influence the normal process of interneuron 
programmed cell death through the activity-dependent inhibition of PTEN, which tips the 
balance between survival and apoptotic signalling pathways in developing interneurons. 
Discussion 
Our results suggest that interneuron programmed cell death has evolved as a mechanism 
responsible for adjusting the final ratio of excitatory and inhibitory neurons in the cerebral 
cortex, a critical milestone in the assembly of cortical circuits38. Although synaptic mechanisms 
are known to stabilise excitatory-inhibitory ratios in cortical circuits39-41, this effectively 
requires that the relative proportions of pyramidal cells and interneurons are within certain 
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parameters42-44. Considering the disproportionate expansion of neocortical areas during human 
evolution45,46, it is tempting to speculate that the dependency of interneuron survival on 
pyramidal cells provides an evolutionary advantage for the preservation of appropriate ratios 
of excitatory and inhibitory cells during the rapid increase of pyramidal cell numbers in the 
primate lineage. 
Our work indicates that interneuron cell death is non-cell autonomously regulated by 
pyramidal cells, which seem to be able to ‘rescue’ connected interneurons from their 
intrinsically determined cell death14 by inhibiting the activity of PTEN during a critical window 
in postnatal development. It is worth noting that a sizable proportion of individuals with autism 
spectrum disorders (ASD) and macrocephaly carry deleterious mutations in the PTEN gene47,48. 
Our observations indicate that loss of PTEN function is sufficient to disrupt interneuron 
programmed cell death, which may in turn alter the cellular balance of excitation and inhibition 
in the cerebral cortex. This mechanism may contribute to deregulation of cortical information 
processing and social dysfunction in ASD patients carrying PTEN mutations.  
The apoptosis rate of pyramidal cells varies among functionally different neocortical areas 
and even across layers within the same cortical area49. This suggests that the proposed 
mechanism may sculpt the heterogeneous patterns of interneuron distributions that exist across 
the cerebral cortex50. Consequently, the regulation of interneuron programmed cell death by 
pyramidal cells likely contributes to the cytoarchitectonical specialisation of cortical areas.  
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FIGURE LEGENDS 
Figure 1 | Consecutive waves of programmed cell death for pyramidal cells and 
interneurons in the early postnatal cortex. a, c, Coronal sections through the primary 
somatosensory cortex (S1) of NexCre;Fucci2 (a) and Nkx2-1-Cre;RCLtdTomato (c) mice during 
postnatal development. b, Total number of pyramidal cells in the entire neocortex of 
NexCre;Fucci2 mice (ANOVA, F = 4.17, *p = 0.02; n = 4 [P2 and P5], 3 [P7] and 5 [P10 and 
P21] animals). d, Total number of MGE/POA interneurons in the entire neocortex of Nkx2-1-
Cre;RCLtdTomato mice (ANOVA, F = 26.80, *p = 0.01; n = 4 animals for all ages). e, Temporal 
variation in pyramidal cell and MGE/POA interneuron percentages. f, Total number of 
MGE/POA interneurons in superficial (L1-L4) and deep layers (L5 and L6) of the neocortex 
(2-way ANOVA, Finteraction = 1.01,*p = 0.03 and **p = 0.002; n = 3 animals for all ages). Data 
is shown as mean ± SEM. Scale bars, 100 µm. 
Figure 2 | Interneuron activity levels predict cell death. a, Schematic of experimental design. 
b, Total number of MGE/POA interneurons in layer 2/3 S1BF of Nkx2-1-Cre;RCLtdTomato mice 
(n = 3 animals for all ages). Data is shown as mean ± SEM. c, ROI imaged at P7 (left) and P8 
(right). d, Raster plots showing the occurrence of calcium events at P7 for the four neurons 
shown in (c). e, Box plots illustrating event rates for P7 interneurons that live past P8 (magenta) 
and interneurons that die by P8. Two-sided Mann-Whitney test, p = 0.03; n = 18 for cells that 
die at P8 and 153 for cells that live beyond P8, from 3 different pups. f, ROC analysis showing 
the ability of P7 event rates to discriminate between cells that die by P8 and cells that live past 
P8, AUC (area under the curve) = 0.65, *p = 0.025. Scale bar, 15 µm. 
Figure 3 | Bidirectional modulation of pyramidal cell activity regulates the extent of 
interneuron cell death. a, Schematic of experimental design. mCherry expression at P21 
following AAV injection at P0. b, c, Coronal sections through S1BF from P21 NexCre/+ mice 
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injected with hM3Dq-mCherry or hM4Di-mCherry viruses followed by vehicle or CNO 
treatment. d, Quantification of the density of PV and SST cells at P21. Two-tailed Student’s 
unpaired t-test, for hM3DQ, ***p = 0.0002, **p = 0.003; for hM4DI, **p = 0.006 [PV], **p = 
0.004 [SST]; for hM3DQ, n = 7 and 9 animals for -CNO PV and SST, respectively; 6 and 7 
animals for +CNO PV and SST, respectively; for hM4DI, n = 7 animals for -CNO and 5 animals 
for +CNO for both PV and SST. Data is shown as mean ± SEM. Scale bars, 500 µm (a) and 
100 µm (b). 
Figure 4 | Survival of pyramidal cells rescues interneuron cell death. a, b, Coronal sections 
through S1BF from P30 Bak+/+;Baxfl/fl  and NexCre/+;Bak-/-;Baxfl/fl (a), and Bak+/-;Baxfl/fl and Nkx2-
1-Cre;Bak-/-;Baxfl/fl (b) mice. c, Quantification of the density of PV and SST cells in pyramidal 
cell-specific Bax/Bak mutant mice, MGE/POA interneuron-specific Bax/Bak mutant mice and 
their respective controls at P30. Two-tailed Student’s unpaired t-test, for NexCre/+, **p = 0.001, 
***p = 0.0002; for Nkx-2-1-Cre, *p = 0.04, ***p = 0.00004; n = 4 animals for NexCre/+;Bak-/-
;Baxfl/fl [PV] and 5 animals for all other groups. Data is shown as mean ± SEM. Scale bar, 100 
µm. 
Figure 5 | Pyramidal cell activity controls interneuron cell survival through PTEN 
inhibition. a, P-Akt, Akt and Actin protein levels in the neocortex. Friedman test, p = 0.001; 
*p = 0.03 for P5 vs P8, *p = 0.0101 for P5 vs P9 and ***p = 0 for P5 vs P7; n = 6 animals for 
all ages. b, Coronal section through layer 2/3 S1BF from Nkx2-1-Cre;RCLtdTomato mice at P8. 
Some interneurons have much higher PTEN levels (arrowhead) than most (open arrowheads). 
c, Coronal sections through layer 2/3 S1BF from Nkx2-1-Cre;RCLtdTomato mice at P5, P7, P8 and 
P10. PTEN expression is shown as a custom LUT in tdTomato-masked cells. d, Cumulative 
distribution of mean PTEN intensity in layer 2/3 MGE interneurons. Kruskal-Wallis, ***p = 
1.7x10-54; n = 223 cells [P5], 184 cells [P7], 394 cells [P8] and 395 cells [P10] from 3 different 
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animals at each age. e, f, Coronal sections through S1BF from Ptenfl/fl and Lhx6-Cre;Ptenfl/fl 
mice at P16. g, Quantification of the density of PV and SST cells in P16 Ptenfl/fl and Lhx6-
Cre;Ptenfl/fl mice. Two-tailed Student’s t-test, *p = 0.04, **p = 0.005; n = 4 Ptenfl/fl and 3 Lhx6-
Cre;Ptenfl/fl animals. h, Schematic of experimental paradigm. i, Coronal sections through layer 
2/3 S1BF from P8 NexCre/+ mice injected with hM3Dq-mCherry at P0 followed by vehicle or 
CNO treatment. PTEN expression is shown as a custom LUT in GABA-masked cells.  j, 
Normalised cumulative distribution of PTEN intensity in layer 2/3 S1BF GABAergic cells in 
vehicle and CNO-treated mice. Kolmogorov-Smirnov test, *** p = 1.05x10-111; n = 1191 cells 
[vehicle] and 3231 cells [CNO] from 4 vehicle and 8 CNO-treated animals.  Data is shown as 
mean ± SEM. Scale bars, 50 μm (b), 100 μm (c, e, f), and 10 μm (j). 
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METHODS 
Animals. All experiments were performed following the guidelines of King’s College London 
Biological Service Unit and in accordance with the European Community Council Directive of 
November 24, 1986 (86/609/EEC). Animal work was carried out under licence from the UK 
Home Office in accordance with the Animals (Scientific Procedures) Act 1986. Both male and 
female mice were used indiscriminately throughout the study. For stereology on pyramidal 
cells, NexCre/+ mice19 (kindly provided by K.A. Nave) were crossed with Fucci2 mice51 
(RCLFucci2aR/+, kindly provided by R.L. Mort). For stereology on MGE/POA interneurons, Nkx2-
1-Cre mice20 (JAX008661) were crossed with RCLtdTomato/tdTomato mice28 (JAX 007909). For in 
vivo calcium imaging experiments, Nkx2-1-Cre;RCLtdTomato/tdTomato mice were crossed with 
RCLGCaMP6s/+ mice29 (JAX024106) to generate Nkx2-1-Cre;RCLtdTomato/ GCaMP6s mice. All designer 
receptor exclusively activated by designer drugs (DREADDs) experiments were conducted in 
mice obtained from crossing NexCre/Cre with CD1 mice. To prevent pyramidal cells from 
undergoing programmed cell death, Bak-/-;BaxFl/Fl  mice33 (JAX006329) were crossed with 
NexCre/Cre  mice and the F1 inter-crossed to obtain Bak+/+;BaxFl/Fl and NexCre/+;Bak-/-;BaxFl/Fl  
mutants. For MGE interneurons, a similar breeding scheme used Nkx2-1-Cre mice instead. For 
the quantification of pyramidal cells in NexCre/+;Bak-/-;BaxFl/Fl , these mutants were crossed with 
Fucci2 mice to obtain NexCre/+;Bak-/-;BaxFl/Fl;RCLFucci2aR/+ mutants. PtenFl/+ mice40 (JAX006440) 
were crossed with Lhx6-Cre mice39 (kindly provided by N. Kessaris) to generate Lhx6-
Cre;PtenFl/+, and F1 inter-crosses led to the production of Lhx6-Cre;PtenFl/Fl mutant mice. Mice 
were obtained from Jackson’s laboratories unless otherwise stated. 
Histology. Mice were anaesthetised with an overdose of sodium pentobarbital and 
transcardially perfused with saline followed by 4% paraformaldehyde (PFA). Brains from pups 
younger than P6 were post-fixed for 4 h while brains from mice older than P6 were post-fixed 
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for 2 h at 4°C. Brains were sectioned either on the sliding microtome at 30 or 40 µm as 
previously described52 or on a vibratome at 40 or 60 µm. All primary and secondary antibodies 
were diluted in PBS containing 0.25% Triton X-100 and 2% BSA. The following antibodies 
were used: goat anti-CTGF (1:200, Santa Cruz), rabbit anti cleaved-caspase-3 (1:200, Cell 
Signalling), rabbit anti-dsRed (1:500, Clontech), goat anti-mCherry (1:500, Antibodies-online), 
rabbit anti-GABA (1:2000, Millipore), mouse anti-GABA (1:500, Sigma), mouse anti-NeuN 
(1:500, Millipore) mouse anti-parvalbumin (1:1000, Swant), rabbit anti-parvalbumin (1:5000, 
Swant), rat anti-somatostatin (1:300, Millipore) and rabbit anti-PTEN (1:500, Abcam). We used 
Alexa Fluor-conjugated secondary antibodies (Invitrogen). For biotin amplification, sections 
were incubated with biotinylated secondary antibody (1:200, Vector labs), followed by Alexa 
Fluor-conjugated Streptavidin (1:200, Vector labs). Blood vessels were stained with Isolectin-
B4-FITC or Isolectin-B4-Dylight 594 (1:500, Vector labs). 
Stereology. The total number of pyramidal neurons and MGE interneurons in the cerebral 
cortex were estimated using the optical dissector method53, 
	𝑁 = 	 𝑄%. 𝑡ℎ	. 𝑎𝑠𝑓. 𝑠𝑠𝑓 
where ΣQ- is the total number of cells counted, t the mean section thickness, h the height of the 
optical dissector (17 µm for pyramidal neuron stereology, 18 µm for MGE stereology), 
adjusting for the guard zones (1 µm) above and below the dissector, asf stands for the area 
sampling fraction and ssf stands for the section sampling fraction (frequency of sampling). An 
ApoTome (Zeiss) equipped with a motorised stage and colour camera was connected to a 
computer with the Stereo Investigator software (MBF Biosciences). The boundaries of the 
neocortex were first defined with a 2.5x objective (Zeiss).  
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For pyramidal neurons, sampling was performed with a 63x objective (Zeiss, numerical 
aperture (NA) 1.4). The counting frame was set at 15 x 15 µm2 and the grid size at 400 x 400 
µm2. The sampling parameters were as follows: asf = 0.0014, ssf = 0.25 (P2); 0.125 (all other 
ages). For MGE interneurons, sampling was performed with a 40x objective (Zeiss, NA 1.3). 
For the entire cortex stereology analysis, the counting frame was set at 125 x 125 µm2 and the 
grid size at 900 x 900 µm2 (P2), 1200 x 1200 µm2 (all other ages). The sampling parameters 
were as follows: asf = 0.019 (P2); 0.011 (all other ages), ssf = 0.125. For the upper/lower 
cortical layer stereology analysis, the counting frame was set at 125 x 125 µm2 and the grid size 
at 900 x 900 µm2. The sampling parameters were as follows: asf = 0.019, ssf = 0.125. For the 
stereological analysis of the barrel field, the counting frame was set at 200 x 200 µm2 and the 
grid size at 350 x 350 µm2. The sampling parameters were as follows: asf = 0.3265, ssf = 0.125. 
In vivo imaging. P6 animals were anesthetized with 2% isoflurane and held in a nose-clamp. 
Isoflurane concentration during surgery was maintained between 1-2% and the body 
temperature was maintained at 37oC by a heating pad. The scalp was cleaned with Betadine and 
cut open to expose the skull covering the dorsal neocortex. The periosteal tissue, surrounding 
the skull, was gently scraped with a scalpel. The skull was cleaned with Betadine and Ringer’s 
solution. A circular custom-made metal head-post (Luigs and Neumann) was attached over the 
left-hemisphere with cyanoacrylate glue (Henkel). A thin protective layer of glue was applied 
over the skull. The glue was allowed to dry for 10 minutes. Dental cement (Paladur) was used 
to reinforce the attachment of the head-post to the skull. The animal was injected with 
Buprenorphine (2 µl/g of a 50 μg/ml solution) and returned to its home cage. 
At P7, the animal was anesthetized and head-restrained in a custom-made head holder. A 3-
mm craniotomy was opened over the posterior-lateral neocortex. This craniotomy encompassed 
the primary somatosensory cortex (S1). Care was taken not to damage the dura mater. A circular 
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coverslip (3 mm diameter, Harvard Apparatus) was placed over the craniotomy and its edges 
were sealed with cyano-acrylate glue and reinforced with dental cement. Following surgery, 
Dexamethasone (5 µl/g of a 38 μg/ml solution) was injected subcutaneously. The animal was 
allowed to recover for at least 2 hours in its home cage, following which we commenced 
imaging at P7. 
Imaging sessions lasted for 40-60 min and we imaged the same field of view for consecutive 
days in 3 mice. TdTomato and GCaMP6s54 were excited using a Ti-Sapphire laser (Coherent 
Chameleon) tuned to λ = 930 nm. The emitted photons were collected by two GaAsP detectors 
through a 20x objective (Olympus, 1.0 NA). The field of view (FOV) measured 385 x 385 μm 
(512 x 512 pixels). The scan speed was set to 30 Hz and image sequences were obtained in 
sweeps of 1 minute (1800 images/channel/minute). The average excitation power was between 
40 and 50 mW, and this was kept constant over all imaging days. 
To correct for motion artefacts, image registration was carried out using custom written 
spatial cross-correlation methods on the tdTomato channel. Briefly, on every 1 min sweep, a 
part of the tdTomato image sequence, where the animal was not moving, was chosen and 20 
frames were averaged to give a non-moving reference image. Every frame of the tdTomato 
image sequence was spatially cross-correlated to this reference image and offset along the X- 
and Y-axes to match the cross-correlation peak. The offsets obtained for each tdTomato frame 
was applied to the corresponding GCaMP6s frame. 
Calcium imaging analysis. Circular ROIs (diameter = 20 pixels) were manually drawn around 
tdTomato expressing cell bodies. The mean GCaMP6s fluorescence intensity in time was 
extracted. Changes in fluorescence signal were calculated as ΔF/F0, where the baseline 
fluorescence (F0) is the mode of a kernel density estimate of F (ksdensity function in Matlab). 
Calcium events were detected by setting a threshold of 3% change in fluorescence from 
baseline. 
 24 
Receiver-operating characteristic (ROC) curves. To identify whether the calcium event rate 
(events/min) at P7 could act as a binary classifier in distinguishing cells that will live and cells 
that die at P8, we plotted the ROC curve55 by varying the discrimination threshold (which, in 
this case, is the P7 event rate) and calculated the area under the curve (AUC). To test for 
statistical significance, the cell labels were randomly shuffled 5000 times. On each shuffle, we 
calculated the ROC curve and the corresponding AUC. We then compared our observed AUC 
to the distribution of shuffled AUCs. The p-value is the fraction of shuffled AUCs ≥ observed 
AUC. 
Intracranial injections. pAAV8-hSyn-DiO-hM3D(Gq)-mCherry and pAAV8-hSyn-DiO-
hM4D(Gi)-mCherry were gifts from Bryan Roth (Addgene plasmids #44361 and #44362)56. P0 
mice were anesthetized with isoflurane and were mounted in a stereotaxic frame. Pups were 
injected with 600 nl of virus diluted in PBS and coloured with 0.5% Fast Green (Sigma). 
Injections were targeted for the somatosensory cortex with an injection rate of 10nl/s.  
Drugs. For DREADDs experiments, Clozapine-N-Oxide (CNO, Tocris) was dissolved in 5% 
dimethyl sulfoxide (Sigma) and then diluted with 0.9% saline to either 1 mg/ml or 5 mg/ml. 
Pups were injected with vehicle (0.05% DMSO) or CNO (1g/10ml) subcutaneously for 4 days, 
twice daily. For the PTEN inhibitor experiments, dipotassium bisperoxovanadium(pic) 
dehydrate (bpV(pic), Sigma) was dissolved in 0.9% saline to 0.2 mg/ml. Pups were injected 
with vehicle (0.9% saline) or bpV(pic) (1g/10ml) intraperitoneally for 2 days, twice daily. All 
treatments for CNO and PTEN inhibitor experiments were randomly assigned. 
Western blotting. Mouse somatosensory cortex tissue was homogenised in RIPA lysis buffer 
containing 50 mM Tris pH 8, 150 mM NaCl, 2 mM EDTA, 0.5% sodium-deoxycholate, 0.1% 
SDS, 1% NP-40 and 1X protease inhibitor cocktail (cOmplete™ Sigma). Samples were 
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denatured in Laemmli Sample Buffer57 and run on 10% SDS–PAGE gels. Separated proteins 
were electrophoretically transferred onto PVDF membranes. Membranes were blocked with 
5% BSA in TBST (20 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.1% Tween20) for 1 h and 
probed with rabbit anti-P-Akt (Ser473, Cell Signalling, 1:1000) overnight at 4°C, followed by 
an HRP-conjugated donkey anti-rabbit antibody (Thermo Fisher, 1:10,000). The blots were 
developed using ECL femto Western blotting detection reagents and following read-out, they 
were stripped (Thermo Fisher). After confirming stripping efficiency, an HRP-conjugated 
mouse anti-Akt antibody (Cell Signalling, 1:1000) was added overnight at 4°C.  The blots were 
developed using ECL western blotting detection reagents the signals were registered and 
following stripping, an HRP-conjugated rabbit anti-Actin (Sigma, 1:20,000) was added for 1 h 
at room temperature. Pico ECL Western blotting reagent was used to detect Actin levels. 
Signals were read on a Li-COR Odyssey Imaging Band intensities were analysed using 
ImageStudioLite. 
Image acquisition. Images used for analysis were obtained from an ApoTome (Zeiss), 
epifluorescence microscope (Leica), or SP8 confocal microscope (Leica). ApoTome images 
were taken using the ApoTome function on the Zen2 software. Images obtained with the 
confocal and epifluorescence microscope were taken using the LAS AF software. 
Cell counting. Cortical layers were identified based on their distinct histological 
characteristics. Layer 1 was identified as a sparsely populated cell layer. The border between 
layers 2/3 and 4 was distinguished by the higher nuclei density of layer 4. Layer 5 was identified 
as the layer basal to layer 4 and above layer 6, which contains less densely packed nuclei. Cell 
density, within cortical layers, was quantified either manually or using custom routines written 
in Matlab (MathWorks). For manual quantification, all analyses were conducted blind and cells 
were counted in a rectangular area, 551.5 µm wide at the pia surface within the somatosensory 
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cortex, auditory cortex or motor cortex. Cells were counted without using pseudocolour in Fiji. 
Automatic quantification was carried out by image segmentation using morphological 
operations. 
To identify PTEN staining intensity in tdTomato+ or GABA+ interneurons, self-designed 
Cell Profiler58 pipelines were used. Briefly, tdTomato+ or GABA+ interneurons were identified 
as primary objects using the global Otsu thresholding method and any objects outside the pre-
set diameter range (25-100 pixels) were excluded. PTEN intensity was measured under this cell 
mask. 
Blood vessel analysis. The fraction of the total area covered by blood vessels and the average 
vessel diameter were quantified using “Vessel Analysis”, an ImageJ plugin 
(http://imagej.net/Vessel_Analysis; Govindaraju and Elfarnawany). 
Statistical analyses. Unless specified, results were plotted and tested for statistical significance 
using Prism 7. The samples were tested for normality using the Shapiro-Wilk normality test. 
Unpaired comparisons were analysed using 2-tailed unpaired Student’s t-test (normally 
distributed) and Mann-Whitney test (not normally distributed). Multiple comparisons with 
single variable were analysed using one-way ANOVA with post hoc Tukey’s test (comparing 
the mean of each column with the mean of every other column) or Dunnett’s test (comparing 
the mean of each column with the mean of a control column) for normally distributed samples. 
For samples with nonparametric distribution, either Kruskal-Wallis (single measures) or 
Friedman’s test (repeated measures) was performed followed by the post hoc Dunn’s test. For 
multiple comparisons with more than one variable, a two-way ANOVA with post hoc Sidak’s 
test was used. The cumulative distributions of PTEN intensity levels were compared using the 
Kolmogorov-Smirnov test. Analysis of calcium events rate was carried out in Matlab. In box 
plots, the central mark indicates the median, and the bottom and top edges of the box indicate 
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the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points 
not considered outliers. Sample sizes were calculated based on similar studies in the literature. 
All experiments were replicated at least in two different litters. 
Data availability. All data and/or analyses generated during the current study are available 
from the corresponding author upon reasonable request.  
Code availability. For automatic quantification, the code was written in Matlab (Mathworks) 
and is available from the corresponding author on reasonable request. 
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EXTENDED DATA FIGURE LEGENDS 
Extended Data Figure 1 | Extensive cell death in layer 2-6 pyramidal cells. a, Coronal 
sections through the S1 cortex of P4 NexCre/+;Fucci2 (left) and P7 Nkx2-1-Cre;RCLtdTomato (right) 
mice immunostained for cleaved caspase-3 (yellow) and mCherry (green, left) or tdTomato 
(magenta, right). b, Quantification of density of cleaved caspase-3 cells in pyramidal neurons 
(left, green bars) and MGE interneurons (right, magenta bars) during postnatal development 
(for pyramidal neurons, ANOVA, F = 73.6, ***p = 0.003 [P2 vs P4], ***p = 0.00006 [P4 vs 
P7], n = 3 animals for all ages; for MGE interneurons, ANOVA, F = 16.91, *p = 0.027 [P5 vs 
P7], **p = 0.0029 [P7 vs P10], n = 3 animals for all ages). c, Coronal sections through the barrel 
cortex of NexCre/+;Fucci2 mice during postnatal development immunostained for mCherry 
(green) and CTGF (yellow). d, Total number of pyramidal cells excluding subplate cells in the 
neocortex of NexCre/+;Fucci2 mice (ANOVA, F = 4.83 and *p = 0.03; n = 3 animals for P2 and 
P5, and 4 animals for P3, P4 and P21). e, Temporal variation in the percentage of pyramidal 
cells excluding the subplate contribution during postnatal development. Data is shown as mean 
± SEM. Scale bars, 100 µm. 
Extended Data Figure 2 | Interneuron cell loss in the barrel field during postnatal 
development. a, Coronal sections through S1BF of Nkx2-1-Cre;RCLtdTomato mice (magenta, 
MGE interneurons) during postnatal development counterstained with DAPI (grey). b, Total 
number of MGE/POA interneurons in S1BF of Nkx2-1-Cre;RCLtdtomato mice during postnatal 
development (ANOVA, F = 6.40 and *p = 0.03; n = 4 animals for all ages). Data is shown as 
mean ± SEM. Scale bar, 100 µm. 
Extended Data Figure 3 | Alteration of pyramidal cell activity affects interneuron density 
but not distribution. a, Coronal sections through S1BF cortex immunostained for GABA 
(magenta) and NeuN (green) and counterstained with DAPI (grey) from P21 NexCre/+ mice 
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injected with hM3Dq-mCherry virus followed by vehicle or CNO treatment. b, Quantification 
of the density of GABA (left) and NeuN+ but GABA- (right) cells in P21 mice injected with 
hM3Dq-mCherry followed by vehicle (grey bars) or CNO (magenta bars) treatment (2-tailed 
Student’s unpaired t-test, **p = 0.005 [GABA], p = 0.68 [NeuN+/GABA-], n = 4 animals for 
vehicle, n = 3 animals for CNO conditions). c, d Quantification of the distribution of PV (left) 
and SST (right) in P21 NexCre/+ mice injected at P0 with hM3Dq-mCherry (c) or hM4Di-
mCherry (d) and treated with vehicle (grey bars) or CNO (magenta bars) during P5-P8 (2-way 
ANOVA, Ftreatment = 0.48, p = 0.50 [hM3Dq PV], Ftreatment = -0.04, p = 0.99 [hM3Dq SST], Ftreatment 
= 0.88, p = 0.37 [hM4DI PV], Ftreatment = 0.79, p = 0.39 [hM4DI SST];  for PV, n = 7 animals 
for hM3Dq and hM4DI -CNO, 6 animals for hM3Dq +CNO, and 5 animals for hM4DI +CNO; 
for SST, n = 9 animals for hM3Dq -CNO, 7 animals for hM3Dq +CNO and hM4Di -CNO, and 
5 animals for hM4DI +CNO). e, Coronal sections through auditory cortex immunostained for 
parvalbumin (PV, magenta, left) or somatostatin (SST, magenta, right)) and counterstained with 
DAPI (grey) from P21 NexCre/+ mice injected with hM3Dq-mCherry viruses followed by vehicle 
or CNO treatment. f, Quantification of the density of PV (right) and SST (left) in auditory cortex 
in P21 mice injected with hM3Dq-mCherry followed by vehicle (grey bars) or CNO (magenta 
bars) treatment (2-tailed Student’s unpaired t-test, p = 0.574 [PV], p = 0.419 [SST], n = 4 
animals for both). Data is shown as mean ± SEM. Scale bars, 100 µm. 
Extended Data Figure 4 | CNO control experiments. a, Schematic of experimental design. 
b, Coronal sections through S1 of P8 NexCre mice injected with AAV8-dio-hM4Di-mCherry at 
P0 and treated with (+CNO) or without (-CNO) between P5 and P8, immunostained for cleaved 
caspase-3 (magenta) and counterstained with DAPI (grey). c, Quantification of the density of 
cleaved caspase-3 cells in P8 mice injected with hM4Di-mCherry and treated (magenta bar) or 
not treated (grey bar) with CNO between P5-P8 (2-tailed Student’s unpaired t-test, ***p 
=0.009, n = 8 animals for -CNO, and n = 7 animals for +CNO). d, Schematic of experimental 
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design for CNO control experiments. e, Quantification of the density of PV (left) and SST 
(right) cells in P21 mice injected with hM3Dq-mCherry or hM4Di-mCherry and not treated 
with CNO (grey bars), or not injected with viruses and treated with CNO (magenta bars) 
between P5-P8 (ANOVA, p = 0.24 [PV] and p = 0.65 [SST] for PV, n = 7 animals for hM3Dq 
and hM4DI -CNO, 4 animals for non-injected +CNO; for SST, n = 9 animals for hM3Dq -
CNO, 7 animals for hM4Di -CNO, and 4 animals for non-injected +CNO). Data is shown as 
mean ± SEM. Scale bar, 100 µm. 
Extended Data Figure 5 | Alteration of pyramidal cell activity beyond the normal period 
of interneuron cell death does not affect interneuron survival or distribution. a, Schematic 
of experimental design. b, c, Coronal sections through S1BF immunostained for parvalbumin 
(PV, b) or somatostatin (SST, c) and counterstained with DAPI (grey) from P21 NexCre/+ mice 
injected with hM3Dq-mCherry (left) and hM4Di-mCherry (right) viruses followed by vehicle 
or CNO treatment. d, g, Quantification of the density of PV (d) and SST (g) cells in P21 
hM3Dq-mCherry injected animals (left bars) and hM4Di-mCherry injected animals (right bars) 
followed by vehicle (grey bars) and CNO (magenta bars) treatment at P10-P13 (2-tailed 
unpaired Student’s t-test, p = 0.99 and p = 0.087 respectively; for SST, 2-tailed unpaired 
Student’s t-test, p = 0.56 and p = 0.37 respectively; n = 4 animals for hM3Dq –CNO and 3 
animals for all other groups)). e, f, h, i, Quantification of the distribution of PV (e, f) and SST 
(h, i) in mice injected with hM3Dq-mCherry (e, h) and hM4Di-mCherry (f, i) followed by 
vehicle (grey bars) or CNO (magenta bars) treatment at P10-P13 (2-way ANOVA, Ftreatment = 
0.15, p = 0.71 [hM3Dq PV], Ftreatment = 0.60, p = 0.48 [hM3Dq SST],  Ftreatment = 1.00, p = 0.37 
[hM4DI PV], Ftreatment = 1.78, p = 0.25 [hM4DI SST]; n = 4 animals for hM3Dq –CNO and 3 
animals for all other groups).  Data is shown as mean ± SEM. Scale bar, 100 µm. 
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Extended Data Figure 6 | Loss of Bak and Bax prevents programmed cell death in 
pyramidal cells. a, Coronal sections through S1BF from P2 and P21 NexCre/+;Bak-/-
;Baxfl/fl;Fucci2 mice immunostained for mCherry (green) and CTGF (yellow). b, Total number 
of pyramidal cells (excluding subplate cells) in the neocortex of NexCre/+;Bak-/-;Baxfl/fl;Fucci2 
mice (2-tailed Student’s unpaired t-test, p = 0.30; n = 3 animals for both ages). Data is shown 
as mean ± SEM. Scale bar, 100 µm. 
Extended Data Figure 7 | Loss of Bak and Bax in pyramidal cells or MGE/POA 
interneurons affects densities but not lamination of MGE/POA interneurons. a, 
Quantification of the distribution of PV (left) and SST (right) interneurons in P30 control (grey 
bars), NexCre/+;Bak-/-;Baxfl/fl (dark magenta bars)  and Nkx2-1-Cre;Bak-/-;Baxfl/fl (light magenta 
bars) mice (2-way ANOVA, Ftreatment = 3.56, p = 0.10 [NexCre/+ PV], Ftreatment = 0.44, p = 0.53 
[Nkx2-1-Cre PV], Ftreatment = 0, p = 0.99 [NexCre/+ SST], Ftreatment = 0.44, p = 0.54 [Nkx2-1-Cre 
SST], n = 4 animals for NexCre/+;Bak-/-;Baxfl/fl [PV] and 5 animals for all other groups). b,  
Quantification of the fold change in the density of PV (top) and SST (bottom) interneurons in 
NexCre/+;Bak-/-;Baxfl/fl (dark magenta bars)  and Nkx2-1-Cre;Bak-/-;Baxfl/fl (light magenta bars) 
mice compared to their respective controls (2-tailed Student’s unpaired t-test, p = 0.90 [PV], p 
= 0.67 [SST], for PV, n = 4 animals for NexCre/+;Bak-/-;Baxfl/fl, 6 animals for Nkx2-1-Cre;Bak-/-
;Baxfl/fl, for SST, n = 5 animals for both NexCre/+;Bak-/-;Baxfl/fl and Nkx2-1-Cre;Bak-/-;Baxfl/fl  ). c, 
Coronal sections through the motor cortex of P30 Bak+/+;Baxfl/fl and NexCre/+;Bak-/-;Baxfl/fl mice 
immunostained for parvalbumin (PV, left) and somatostatin (SST, right) and counterstained 
with DAPI (grey). d, Quantification of the density of PV (left) and SST (right) cells in the motor 
cortex control and pyramidal cell-specific Bax/Bak double mutant mice at P30 (2-tailed 
Student’s unpaired t-test, *p = 0.02 [PV], *p = 0.01 [SST], for PV, n = 4 animals for both and 
for SST, n = 3 animals for both). Data is shown as mean ± SEM. Scale bar, 100 µm. 
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Extended Data Figure 8 | PTEN expression in deep layer cortical interneurons and effects 
of loss of Pten function on neurons and blood vessels. a, Coronal sections through layer 5 of 
S1BF from Nkx2-1-Cre;RCLtdTomato mice at P5, P7, P8 and P10, immunostained PTEN and 
counterstained with DAPI (grey). PTEN expression is shown as a custom LUT in tdTomato-
masked cells. b, Cumulative distribution of mean PTEN intensity in layer 5 and 6 MGE/POA 
interneurons (Kruskal-Wallis test, ***p = 0; n = 7270 cells [P5], 4544 cells [P7], 6780 cells 
[P8] and 5043 cells [P10] from 3 different animals at each age). c, Coronal sections through 
S1BF from Ptenfl/fl and Lhx6-Cre;Ptenfl/fl mice at P16 immunostained for GABA (red, left), 
NeuN (green, middle) and isolectin B4 (IB4, cyan, right) and counterstained with DAPI (grey). 
d, Quantification of the density of GABA (far left), NeuN+ but GABA- (left) cells, and vessel 
area (right) and diameter (far right) in P16 Ptenfl/fl (grey bars) and Lhx6-Cre;Ptenfl/fl (magenta 
bars) animals (2-tailed unpaired Student’s t-test, **p = 0.0035 [GABA], *p = 0.0326 [vessel 
area], p = 0.0810 [vessel diameter]; Kolmogorov-Smirnov test, p = 0.1000 [NeuN+/GABA- 
cells], n = 3 animals for both genotypes). e, Quantification of the distribution of PV (left), SST 
(right) cells in P16 Ptenfl/fl (grey bars) and Lhx6-Cre;Ptenfl/fl (magenta bars) mice (2-way 
ANOVA, Fgenotype= 0.29, p = 0.61 [PV]; Fgenotype= 0.0004, p = 0.98 [SST]; n = 4 Ptenfl/fl animals 
and 3 Lhx6-Cre;Ptenfl/fl animals). Data is shown as mean ± SEM. Scale bars, 100 µm. 
Extended Data Figure 9 | Pharmacological PTEN inhibition during the interneuron cell 
death period increases interneuron survival. a, f, Schematics of experimental design. b, 
Coronal sections through S1BF from P10 mice injected at P7-P8 with vehicle (left) or BpV(pic) 
(right) stained for isolectin B4 (IB4, cyan) and DAPI (grey). c, Quantification of blood vessel 
area (left) and diameter (right) in P10 mice treated with vehicle (grey bars) or BpV(pic) 
(magenta bars) (Kolmogorov-Smirnov test [vessel area], p = 0.60; 2-tailed unpaired Student’s 
t-test [vessel diameter], p = 0.58, n = 3 animals for each group). d, g, Coronal sections through 
S1BF from P21 mice injected at P7-P8 (d) or P12-P13 (g) with vehicle (left) or BpV(pic) (right) 
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and immunostained for PV and SST and counterstained with DAPI. e, h, Quantification of the 
density of PV (left) and SST (right) in S1BF from P21 mice injected at P7-P8 (e) or P12-P13 
(h) with vehicle (grey bars) or BpV(pic) (magenta bars) (P7-P8 groups: 2-tailed unpaired 
Student’s t-test, *p = 0.04 [PV], *p = 0.03 [SST]; n = 7 animals for each group, P12-P13 groups: 
2-tailed unpaired Student’s t-test, p = 0.84 [PV], p = 0.82 [SST], n = 5 animals for each group). 
Data is shown as mean ± SEM. Scale bars, 100 µm. 
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METHODS 
Animals. All experiments were performed following the guidelines of King’s College 
London Biological Service Unit and in accordance with the European Community Council 
Directive of November 24, 1986 (86/609/EEC). Animal work was carried out under licence 
from the UK Home Office in accordance with the Animals (Scientific Procedures) Act 1986. 
For stereology on pyramidal cells, NexCre/+ mice19 (kindly provided by K.A. Nave) were 
crossed with Fucci2 mice53 (RCLFucci2aR/+, kindly provided by R.L. Mort). For stereology on 
MGE/POA-derived interneurons, Nkx2-1-Cre mice20 (JAX008661) were crossed with 
RCLtdTomato/tdTomato mice28 (JAX 007909). For in vivo calcium imaging experiments, Nkx2-1-
Cre;RCLtdTomato/tdTomato mice were crossed with RCLGCaMP6s/+ mice29 (JAX024106) to generate 
Nkx2-1-Cre;RCLtdTomato/ GCaMP6s mice. All designer receptor exclusively activated by designer 
drugs (DREADDs) experiments were conducted in mice obtained from crossing NexCre/Cre 
with CD1 mice. To prevent pyramidal cells from undergoing programmed cell death, Bak-/-
;BaxFl/Fl  mice33 (JAX006329) were crossed with NexCre/Cre  mice and the F1 inter-crossed to 
obtain Bak+/+;BaxFl/Fl and NexCre/+;Bak-/-;BaxFl/Fl  mutants. For MGE interneurons, a similar 
breeding scheme used Nkx2-1-Cre mice instead. For the quantification of pyramidal cells in 
NexCre/+;Bak-/-;BaxFl/Fl , these mutants were crossed with Fucci2 mice to obtain NexCre/+;Bak-/-
;BaxFl/Fl;RCLFucci2aR/+ mutants. PtenFl/+ mice40 (JAX006440) were crossed with Lhx6-Cre 
mice39 (kindly provided by N. Kessaris) to generate Lhx6-Cre;PtenFl/+, and F1 inter-crosses 
led to the production of Lhx6-Cre;PtenFl/Fl mutant mice. Mice were obtained from Jackson’s 
laboratories unless otherwise stated. 
Histology. Mice were anaesthetised with an overdose of sodium pentobarbital and 
transcardially perfused with saline followed by 4% paraformaldehyde (PFA). Brains from 
pups younger than P6 were post-fixed for 4 h while brains from mice older than P6 were 
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post-fixed for 2 h at 4°C. Brains were sectioned either on the sliding microtome at 30 or 40 
µm as previously described54 or on a vibratome at 40 or 60 µm. All primary and secondary 
antibodies were diluted in PBS containing 0.25% Triton X-100 and 2% BSA. The following 
antibodies were used: goat anti-CTGF (1:200, Santa Cruz), rabbit anti cleaved-caspase-3 
(1:200, Cell Signalling), rabbit anti-dsRed (1:500, Clontech), goat anti-mCherry (1:500, 
Antibodies-online), rabbit anti-GABA (1:2000, Millipore), mouse anti-GABA (1:500, Sigma), 
mouse anti-NeuN (1:500, Millipore) mouse anti-parvalbumin (1:1000, Swant), rabbit anti-
parvalbumin (1:5000, Swant), rat anti-somatostatin (1:300, Millipore) and rabbit anti-PTEN 
(1:500, Abcam). We used Alexa Fluor-conjugated secondary antibodies (Invitrogen). For 
biotin amplification, sections were incubated with biotinylated secondary antibody (1:200, 
Vector), followed by Alexa Fluor-conjugated Streptavidin (1:200, Vector). Blood vessels 
were stained with Isolectin-B4-FITC or Isolectin-B4-Dylight 594 (1:500, Vectorlabs). 
Stereology 
The total number of pyramidal neurons and MGE interneurons in the cerebral cortex were 
estimated using the optical dissector method55,   
𝑁 =	 𝑄%. 𝑡ℎ	. 𝑎𝑠𝑓. 𝑠𝑠𝑓 
where ΣQ- is the total number of cells counted, t the mean section thickness, h the height 
of the optical dissector (17 µm for pyramidal neuron stereology, 18 µm for MGE stereology), 
adjusting for the guard zones (1 µm) above and below the dissector, asf stands for the area 
sampling fraction and ssf stands for the section sampling fraction (frequency of sampling). 
An ApoTome (Zeiss) equipped with a motorised stage and colour camera was connected to a 
computer with the Stereo Investigator software (MBF Biosciences). The boundaries of the 
neocortex were first defined with a 2.5x objective (Zeiss).  
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For pyramidal neurons, sampling was performed with a 63x objective (Zeiss, numerical 
aperture (NA) 1.4). The counting frame was set at 15 x 15 µm2 and the grid size at 400 x 400 
µm2. The sampling parameters were as follows: asf = 0.0014, ssf = 0.25 (P2); 0.125 (all other 
ages). For MGE interneurons, sampling was performed with a 40x objective (Zeiss, NA 1.3). 
For the entire cortex stereology analysis, the counting frame was set at 125 x 125 µm2 and the 
grid size at 900 x 900 µm2 (P2), 1200 x 1200 µm2 (all other ages). The sampling parameters 
were as follows: asf = 0.019 (P2); 0.011 (all other ages), ssf = 0.125. For the upper/lower 
cortical layer stereology analysis, the counting frame was set at 125 x 125 µm2 and the grid 
size at 900 x 900 µm2. The sampling parameters were as follows: asf = 0.019, ssf = 0.125. For 
the stereological analysis of the barrel field, the counting frame was set at 200 x 200 µm2 and 
the grid size at 350 x 350 µm2. The sampling parameters were as follows: asf = 0.3265, ssf = 
0.125. 
In vivo imaging. P6 animals were anesthetized with 2% isoflurane and held in a nose-clamp. 
Isoflurane concentration during surgery was maintained between 1-2% and the body 
temperature was maintained at 37oC by a heating pad. The scalp was cleaned with Betadine 
and cut open to expose the skull covering the dorsal neocortex. The periosteal tissue, 
surrounding the skull, was gently scraped with a scalpel. The skull was cleaned with Betadine 
and Ringer’s solution. A circular custom-made metal head-post (Luigs and Neumann) was 
attached over the left-hemisphere with cyanoacrylate glue (Henkel). A thin protective layer of 
glue was applied over the skull. The glue was allowed to dry for 10 minutes. Dental cement 
(Paladur) was used to reinforce the attachment of the head-post to the skull. The animal was 
injected with Buprenorphine (2 µl/g of a 50 μg/ml solution) and returned to its home cage. 
At P7, the animal was anesthetized and head-restrained in a custom-made head holder. A 3 
mm craniotomy was opened over the posterior-lateral neocortex. This craniotomy 
encompassed the primary somatosensory cortex (S1). Care was taken not to damage the dura 
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mater. A circular coverslip (3 mm diameter, Harvard Apparatus) was placed over the 
craniotomy and its edges were sealed with cyano-acrylate glue and reinforced with dental 
cement. Following surgery, Dexamethasone (5 µl/g of a 38 μg/ml solution) was injected 
subcutaneously. The animal was allowed to recover for at least 2 hours in its home cage, 
following which we commenced imaging at P7. 
Imaging sessions lasted for 40-60 min and we imaged the same field of view for 
consecutive days in 3 mice. TdTomato and GCaMP6s56 were excited using a Ti-Sapphire 
laser (Coherent Chameleon) tuned to λ = 930 nm. The emitted photons were collected by two 
GaAsP detectors through a 20x objective (Olympus, 1.0 NA). The field of view (FOV) 
measured 385 x 385 μm (512 x 512 pixels). The scan speed was set to 30 Hz and image 
sequences were obtained in sweeps of 1 minute (1800 images/channel/minute). The average 
excitation power was between 40 and 50 mW, and this was kept constant over all imaging 
days. 
To correct for motion artefacts, image registration was carried out using custom written 
spatial cross-correlation methods on the tdTomato channel. Briefly, on every 1 min sweep, a 
part of the tdTomato image sequence, where the animal was not moving, was chosen and 20 
frames were averaged to give a non-moving reference image. Every frame of the tdTomato 
image sequence was spatially cross-correlated to this reference image and offset along the X- 
and Y-axes to match the cross-correlation peak. The offsets obtained for each tdTomato 
frame was applied to the corresponding GCaMP6s frame. 
Calcium imaging analysis. Circular ROIs (diameter = 20 pixels) were manually drawn 
around tdTomato expressing cell bodies. The mean GCaMP6s fluorescence intensity in time 
was extracted. Changes in fluorescence signal were calculated as ΔF/F0, where the baseline 
fluorescence (F0) is the mode of a kernel density estimate of F (ksdensity function in Matlab). 
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Calcium events were detected by setting a threshold of 3% change in fluorescence from 
baseline. 
Receiver-operating characteristic (ROC) curves. To identify whether the calcium event 
rate (events/min) at P7 could act as a binary classifier in distinguishing cells that will live and 
cells that die at P8, we plotted the ROC curve57 by varying the discrimination threshold 
(which, in this case, is the P7 event rate) and calculated the area under the curve (AUC). To 
test for statistical significance, the cell labels were randomly shuffled 5000 times. On each 
shuffle, we calculated the ROC curve and the corresponding AUC. We then compared our 
observed AUC to the distribution of shuffled AUCs. The p-value is the fraction of shuffled 
AUCs ≥ observed AUC. 
Intracranial injections. pAAV8-hSyn-DiO-hM3D(Gq)-mCherry and pAAV8-hSyn-DiO-
hM4D(Gi)-mCherry were gifts from Bryan Roth (Addgene plasmids #44361 and #44362)58. 
P0 mice were anesthetized with isoflurane and were mounted in a stereotaxic frame. Pups 
were injected with 600 nl of virus diluted in PBS and coloured with 0.5% Fast Green (Sigma). 
Injections were targeted for the somatosensory cortex with an injection rate of 10nl/s.  
Drugs. For DREADDs experiments, Clozapine-N-Oxide (CNO, Tocris) was dissolved in 5% 
dimethyl sulfoxide (Sigma) and then diluted with 0.9% saline to either 1 mg/ml or 5 mg/ml. 
Pups were injected with vehicle (0.05% DMSO) or CNO (1g/10ml) subcutaneously for 4 
days, twice daily. For the PTEN inhibitor experiments, dipotassium bisperoxovanadium(pic) 
dehydrate (bpV(pic), Sigma) was dissolved in 0.9% saline to 0.2 mg/ml. Pups were injected 
with vehicle (0.9% saline) or bpV(pic) (1g/10ml) intraperitoneally for 2 days, twice daily. 
Western blotting. Mouse somatosensory cortex tissue was homogenised in RIPA lysis 
buffer containing 50 mM Tris pH 8, 150 mM NaCl, 2 mM EDTA, 0.5% sodium-
deoxycholate, 0.1% SDS, 1% NP-40 and 1X protease inhibitor cocktail (cOmplete™ Sigma). 
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Samples were denatured in Laemmli Sample Buffer59 and run on 10% SDS–PAGE gels. 
Separated proteins were electrophoretically transferred onto PVDF membranes. Membranes 
were blocked with 5% BSA in TBST (20 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.1% 
Tween20) for 1 h and probed with rabbit anti-P-Akt (Ser473, Cell Signalling, 1:1000) 
overnight at 4°C, followed by an HRP-conjugated donkey anti-rabbit antibody (Thermo 
Fisher, 1:10,000). The blots were developed using ECL femto Western blotting detection 
reagents and following read-out, they were stripped (Thermo Fisher). After confirming 
stripping efficiency, an HRP-conjugated mouse anti-Akt antibody (Cell Signalling, 1:1000) 
was added overnight at 4°C.  The blots were developed using ECL western blotting detection 
reagents the signals were registered and following stripping, an HRP-conjugated rabbit anti-
Actin (Sigma, 1:20,000) was added for 1 h at room temperature. Pico ECL Western blotting 
reagent was used to detect Actin levels. Signals were read on a Li-COR Odyssey Imaging 
Band intensities were analysed using ImageStudioLite. 
Image acquisition. Images used for analysis were obtained from an ApoTome (Zeiss), 
epifluorescence microscope (Leica), or SP8 confocal microscope (Leica). ApoTome images 
were taken using the ApoTome function on the Zen2 software. Images obtained with the 
confocal and epifluorescence microscope were taken using the LAS AF software. 
Cell counting. Cortical layers were identified based on their distinct histological 
characteristics. Layer 1 was identified as a sparsely populated cell layer. The border between 
layers 2/3 and 4 was distinguished by the higher nuclei density of layer 4. Layer 5 was 
identified as the layer basal to layer 4 and above layer 6, which contains less densely packed 
nuclei. Cell density, within cortical layers, was quantified either manually or using custom 
routines written in Matlab (MathWorks). For manual quantification, cells were counted in a 
rectangular area, 551.5 µm wide at the pia surface within the somatosensory cortex, auditory 
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cortex or motor cortex. Cells were counted without using pseudocolour in Fiji. Automatic 
quantification was carried out by image segmentation using morphological operations. 
To identify PTEN staining intensity in tdTomato+ or GABA+ interneurons, self-designed 
Cell Profiler60 pipelines were used. Briefly, tdTomato+ or GABA+ interneurons were 
identified as primary objects using the global Otsu thresholding method and any objects 
outside the pre-set diameter range (25-100 pixels) were excluded. PTEN intensity was 
measured under this cell mask. 
Blood vessel analysis. The fraction of the total area covered by blood vessels and the average 
vessel diameter were quantified using “Vessel Analysis”, an ImageJ plugin 
(http://imagej.net/Vessel_Analysis; Govindaraju and Elfarnawany). 
Statistical analyses. Unless specified, results were plotted and tested for statistical 
significance using Prism 7. The samples were tested for normality using the Shapiro-Wilk 
normality test. Unpaired comparisons were analysed using 2-tailed unpaired Student’s t-test 
(normally distributed) and Mann-Whitney test (not normally distributed). Multiple 
comparisons with single variable were analysed using one-way ANOVA with post hoc 
Tukey’s test (comparing the mean of each column with the mean of every other column) or 
Dunnett’s test (comparing the mean of each column with the mean of a control column) for 
normally distributed samples. For samples with nonparametric distribution, either Kruskal-
Wallis (single measures) or Friedman’s test (repeated measures) was performed followed by 
the post hoc Dunn’s test. For multiple comparisons with more than one variable, a two-way 
ANOVA with post hoc Sidak’s test was used. The cumulative distributions of PTEN intensity 
levels were compared using the Kolmogorov-Smirnov test. Analysis of calcium events rate 
was carried out in Matlab. 
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Data availability. Datasets generated and analysed during the current study are available in 
the online version of the paper. 
Code availability. For automatic quantification, the code was written in Matlab (Mathworks) 
and is available from the corresponding author on reasonable request. 
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Extended Data Figure 1 | Extensive cell death in layer 2-6 pyramidal cells. a, Coronal 
sections through the S1 cortex of P4 NexCre/+;Fucci2 (left) and P7 Nkx2-1-Cre;RCLtdTomato 
(right) mice immunostained for cleaved caspase-3 (yellow) and mCherry (green, left) or 
tdTomato (magenta, right). b, Quantification of density of cleaved caspase-3 cells in 
pyramidal neurons (left, green bars) and MGE interneurons (right, magenta bars) during 
postnatal development (for pyramidal neurons, ANOVA, F = 73.6, ***p = 0.003 [P2 vs P4], 
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***p < 0.0001 [P4 vs P7], n = 3 animals for all ages; for MGE interneurons, ANOVA, F = 
16.91, *p = 0.027 [P5 vs P7], **p = 0.0029 [P7 vs P10], n = 3 animals for all ages). c, 
Coronal sections through the barrel cortex of NexCre/+;Fucci2 mice during postnatal 
development immunostained for mCherry (green) and CTGF (yellow). d, Total number of 
pyramidal cells excluding subplate cells in the neocortex of NexCre/+;Fucci2 mice (ANOVA, F 
= 4.83 and *p = 0.03; n = 3 animals for P2 and P5, and 4 animals for P3, P4 and P21). e, 
Temporal variation in the percentage of pyramidal cells excluding the subplate contribution 
during postnatal development. Data is shown as mean ± SEM. Scale bars, 100 µm. 	  
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Extended Data Figure 2 | Interneuron cell loss in the barrel field during postnatal 
development. a, Coronal sections through S1BF of Nkx2-1-Cre;RCLtdTomato mice (magenta, 
MGE interneurons) during postnatal development counterstained with DAPI (grey). b, Total 
number of MGE-derived interneurons in S1BF of Nkx2-1-Cre;RCLtdtomato mice during 
postnatal development (ANOVA, F = 6.40 and *p = 0.03; n = 4 animals for all ages). Data is 
shown as mean ± SEM. Scale bar, 100 µm. 	  
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Extended Data Figure 3 | Alteration of pyramidal cell activity affects interneuron 
density but not distribution. a, Coronal sections through S1BF cortex immunostained for 
GABA (magenta) and NeuN (green) and counterstained with DAPI (grey) from P21 NexCre/+ 
mice injected with hM3Dq-mCherry virus followed by vehicle or CNO treatment. b, 
Quantification of the density of GABA (left) and NeuN+ but GABA- (right) cells in P21 
mice injected with hM3Dq-mCherry followed by vehicle (grey bars) or CNO (magenta bars) 
treatment (2-tailed Student’s unpaired t-test, **p = 0.005 [GABA], p = 0.68 [NeuN+/GABA-
], n = 4 animals for vehicle, n = 3 animals for CNO conditions). c, d Quantification of the 
distribution of PV (left) and SST (right) in P21 NexCre/+ mice injected at P0 with hM3Dq-
mCherry (c) or hM4Di-mCherry (d) and treated with vehicle (grey bars) or CNO (magenta 
bars) during P5-P8 (2-way ANOVA, Ftreatment = 0.48, p = 0.50 [hM3Dq PV], Ftreatment = -0.04, p 
= 0.99 [hM3Dq SST], Ftreatment = 0.88, p = 0.37 [hM4DI PV], Ftreatment = 0.79, p = 0.39 [hM4DI 
SST];  for PV, n = 7 animals for hM3Dq and hM4DI -CNO, 6 animals for hM3Dq +CNO, 
and 5 animals for hM4DI +CNO; for SST, n = 9 animals for hM3Dq -CNO, 7 animals for 
hM3Dq +CNO and hM4Di -CNO, and 5 animals for hM4DI +CNO). e, Coronal sections 
through auditory cortex immunostained for parvalbumin (PV, magenta, left) or somatostatin 
(SST, magenta, right)) and counterstained with DAPI (grey) from P21 NexCre/+ mice injected 
with hM3Dq-mCherry viruses followed by vehicle or CNO treatment. f, Quantification of the 
density of PV (right) and SST (left) in auditory cortex in P21 mice injected with hM3Dq-
mCherry followed by vehicle (grey bars) or CNO (magenta bars) treatment (2-tailed 
Student’s unpaired t-test, p = 0.574 [PV], p = 0.419 [SST], n = 4 animals for both). Data is 
shown as mean ± SEM. Scale bars, 100 µm. 
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Extended Data Figure 4 | CNO control experiments. a, Schematic of experimental design. 
b, Coronal sections through S1 of P8 NexCre mice injected with AAV8-dio-hM4Di-mCherry at 
P0 and treated with (+CNO) or without (-CNO) between P5 and P8, immunostained for 
cleaved caspase-3 (magenta) and counterstained with DAPI (grey). c, Quantification of the 
density of cleaved caspase-3 cells in P8 mice injected with hM4Di-mCherry and treated 
(magenta bar) or not treated (grey bar) with CNO between P5-P8 (2-tailed Student’s unpaired 
t-test, ***p =0.009, n = 8 animals for -CNO, and n = 7 animals for +CNO). d, Schematic of 
experimental design for CNO control experiments. e, Quantification of the density of PV 
(left) and SST (right) cells in P21 mice injected with hM3Dq-mCherry or hM4Di-mCherry 
and not treated with CNO (grey bars), or not injected with viruses and treated with CNO 
(magenta bars) between P5-P8 (ANOVA, p = 0.24 [PV] and p = 0.65 [SST] for PV, n = 7 
	 16 
animals for hM3Dq and hM4DI -CNO, 4 animals for non-injected +CNO; for SST, n = 9 
animals for hM3Dq -CNO, 7 animals for hM4Di -CNO, and 4 animals for non-injected 
+CNO). Data is shown as mean ± SEM. Scale bar, 100 µm. 	  
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Extended Data Figure 5 | Alteration of pyramidal cell activity beyond the normal period 
of interneuron cell death does not affect interneuron survival or distribution. a, 
Schematic of experimental design. b, c, Coronal sections through S1BF immunostained for 
parvalbumin (PV, b) or somatostatin (SST, c) and counterstained with DAPI (grey) from P21 
NexCre/+ mice injected with hM3Dq-mCherry (left) and hM4Di-mCherry (right) viruses 
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followed by vehicle or CNO treatment. d, g, Quantification of the density of PV (d) and SST 
(g) cells in P21 hM3Dq-mCherry injected animals (left bars) and hM4Di-mCherry injected 
animals (right bars) followed by vehicle (grey bars) and CNO (magenta bars) treatment at 
P10-P13 (2-tailed unpaired Student’s t-test, p = 0.99 and p = 0.087 respectively; for SST, 2-
tailed unpaired Student’s t-test, p = 0.56 and p = 0.37 respectively; n = 4 animals for hM3Dq 
–CNO and 3 animals for all other groups)). e, f, h, i, Quantification of the distribution of PV 
(e, f) and SST (h, i) in mice injected with hM3Dq-mCherry (e, h) and hM4Di-mCherry (f, i) 
followed by vehicle (grey bars) or CNO (magenta bars) treatment at P10-P13 (2-way 
ANOVA, Ftreatment = 0.15, p = 0.71 [hM3Dq PV], Ftreatment = 0.60, p = 0.48 [hM3Dq SST],  
Ftreatment = 1.00, p = 0.37 [hM4DI PV], Ftreatment = 1.78, p = 0.25 [hM4DI SST]; n = 4 animals 
for hM3Dq –CNO and 3 animals for all other groups).  Data is shown as mean ± SEM. Scale 
bar, 100 µm. 	  
	 19 
 
Extended Data Figure 6 | Loss of Bak and Bax prevents programmed cell death in 
pyramidal cells. a, Coronal sections through S1BF from P2 and P21 NexCre/+;Bak-/-
;Baxfl/fl;Fucci2 mice immunostained for mCherry (green) and CTGF (yellow). b, Total 
number of pyramidal cells (excluding subplate cells) in the neocortex of NexCre/+;Bak-/-
;Baxfl/fl;Fucci2 mice (2-tailed Student’s unpaired t-test, p = 0.30; n = 3 animals for both ages). 
Data is shown as mean ± SEM. Scale bar, 100 µm. 
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Extended Data Figure 7 | Loss of Bak and Bax in pyramidal cells or MGE-derived 
interneurons affects densities but not lamination of MGE-derived interneurons. a, 
Quantification of the distribution of PV (left) and SST (right) interneurons in P30 control 
(grey bars), NexCre/+;Bak-/-;Baxfl/fl (dark magenta bars)  and Nkx2-1-Cre;Bak-/-;Baxfl/fl (light 
magenta bars) mice (2-way ANOVA, Ftreatment = 3.56, p = 0.10 [NexCre/+ PV], Ftreatment = 0.44, p 
= 0.53 [Nkx2-1-Cre PV], Ftreatment = 0, p = 0.99 [NexCre/+ SST], Ftreatment = 0.44, p = 0.54 [Nkx2-
1-Cre SST], n = 4 animals for NexCre/+;Bak-/-;Baxfl/fl [PV] and 5 animals for all other groups). 
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b,  Quantification of the fold change in the density of PV (top) and SST (bottom) 
interneurons in NexCre/+;Bak-/-;Baxfl/fl (dark magenta bars)  and Nkx2-1-Cre;Bak-/-;Baxfl/fl (light 
magenta bars) mice compared to their respective controls (2-tailed Student’s unpaired t-test, p 
= 0.90 [PV], p = 0.67 [SST], for PV, n = 4 animals for NexCre/+;Bak-/-;Baxfl/fl, 6 animals for 
Nkx2-1-Cre;Bak-/-;Baxfl/fl, for SST, n = 5 animals for both NexCre/+;Bak-/-;Baxfl/fl and Nkx2-1-
Cre;Bak-/-;Baxfl/fl  ). c, Coronal sections through the motor cortex of P30 Bak+/+;Baxfl/fl and 
NexCre/+;Bak-/-;Baxfl/fl mice immunostained for parvalbumin (PV, left) and somatostatin (SST, 
right) and counterstained with DAPI (grey). d, Quantification of the density of PV (left) and 
SST (right) cells in the motor cortex control and pyramidal cell-specific Bax/Bak double 
mutant mice at P30 (2-tailed Student’s unpaired t-test, *p = 0.02 [PV], *p = 0.01 [SST], for 
PV, n = 4 animals for both and for SST, n = 3 animals for both). Data is shown as mean ± 
SEM. Scale bar, 100  µm. 
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Extended Data Figure 8 | PTEN expression in deep layer cortical interneurons and 
effects of loss of Pten function on neurons and blood vessels. a, Coronal sections through 
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layer 5 of S1BF from Nkx2-1-Cre;RCLtdTomato mice at P5, P7, P8 and P10, immunostained 
PTEN and counterstained with DAPI (grey). PTEN expression is shown as a custom LUT in 
tdTomato-masked cells. b, Cumulative distribution of mean PTEN intensity in layer 5 and 6 
MGE-derived interneurons (Kruskal-Wallis test, ***p < 0.0001; n = 7270 cells [P5], 4544 
cells [P7], 6780 cells [P8] and 5043 cells [P10] from 3 different animals at each age). c, 
Coronal sections through S1BF from Ptenfl/fl and Lhx6-Cre;Ptenfl/fl mice at P16 
immunostained for GABA (red, left), NeuN (green, middle) and isolectin B4 (IB4, cyan, 
right) and counterstained with DAPI (grey). d, Quantification of the density of GABA (far 
left), NeuN+ but GABA- (left) cells, and vessel area (right) and diameter (far right) in P16 
Ptenfl/fl (grey bars) and Lhx6-Cre;Ptenfl/fl (magenta bars) animals (2-tailed unpaired Student’s 
t-test, **p = 0.0035 [GABA], *p = 0.0326 [vessel area], p = 0.0810 [vessel diameter]; 
Kolmogorov-Smirnov test, p = 0.1000 [NeuN+/GABA- cells], n = 3 animals for both 
genotypes). e, Quantification of the distribution of PV (left), SST (right) cells in P16 Ptenfl/fl 
(grey bars) and Lhx6-Cre;Ptenfl/fl (magenta bars) mice (2-way ANOVA, Fgenotype= 0.29, p = 
0.61 [PV]; Fgenotype= 0.0004, p = 0.98 [SST]; n = 4 Ptenfl/fl animals and 3 Lhx6-Cre;Ptenfl/fl 
animals). Data is shown as mean ± SEM. Scale bars, 100 µm. 
	  
	 24 
 
Extended Data Figure 9 | Pharmacological PTEN inhibition during the interneuron cell 
death period increases interneuron survival. a, f, Schematics of experimental design. b, 
Coronal sections through S1BF from P10 mice injected at P7-P8 with vehicle (left) or 
BpV(pic) (right) stained for isolectin B4 (IB4, cyan) and DAPI (grey). c, Quantification of 
blood vessel area (left) and diameter (right) in P10 mice treated with vehicle (grey bars) or 
BpV(pic) (magenta bars) (Kolmogorov-Smirnov test [vessel area], p = 0.60; 2-tailed unpaired 
Student’s t-test [vessel diameter], p = 0.58, n = 3 animals for each group). d, g, Coronal 
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sections through S1BF from P21 mice injected at P7-P8 (d) or P12-P13 (g) with vehicle (left) 
or BpV(pic) (right) and immunostained for PV and SST and counterstained with DAPI. e, h, 
Quantification of the density of PV (left) and SST (right) in S1BF from P21 mice injected at 
P7-P8 (e) or P12-P13 (h) with vehicle (grey bars) or BpV(pic) (magenta bars) (P7-P8 groups: 
2-tailed unpaired Student’s t-test, *p = 0.04 [PV], *p = 0.03 [SST]; n = 7 animals for each 
group, P12-P13 groups: 2-tailed unpaired Student’s t-test, p = 0.84 [PV], p = 0.82 [SST], n = 
5 animals for each group). Data is shown as mean ± SEM. Scale bars, 100 µm. 
 
FIGURE 1 Measurement Values N Statistical P value
Fig 1b Pyramidal neurons in whole cortex (mean ± SEM)
P2: 4158309.25 ± 133081.90; P5: 3558856.75  ± 153905.82; P7: 
3652755.67  ± 9751.10; P10: 3693178.80  ± 92500.28; P21: 
3585341  ± 11644.40
[brains] P2, n = 4; P5, n = 4; P7, n = 3; P10, n = 5; P21, n = 5 One-way ANOVA with Tukey's test
P2 vs P5,  p = 0.0215 (*); P2 vs 
P21, p = 0.0204 (*)
Fig 1d MGE interneurons in  whole cortex (mean ± SEM)
P2: 679604± 32053; P5: 684715  ± 17839 P7: 571140  ± 22834 
P10: 488499  ± 14848 P21: 453205  ± 18326 [brains] P2, n = 4; P5, n = 4; P7, n = 4; P10, n = 4; P21, n = 4
One-way ANOVA with 
Tukey's test
P5 vs P7, p = 0.0116 (*); P5 vs P10, 
p < 0.001 (***); P5 vs P21, p < 
0.001 (***)
Fig 1e
Percentage change of 
pyramidal neuron and MGE  
interneurons (mean ± SEM)
Pyramidal cells: P2: 0 ± 3.20; P5: 14.42 ± 3.70; P7: 12.16 ± 0.23; 
P10: 11.19 ± 2.22; P21: 13.78 ± 2.8 
MGE cells:  P2: 0 ± 4.72; P5: -0.75 ± 3.35; P7: 15.95 ± 3.35; P10: 
28.12 ± 2.19; P21: 33.31 ± 2.70
Pyramidal cell [brains]P2, n = 4; P5, n = 4; P7, n = 3; P10, n = 5; P21, n = 5                                                  
MGE  [brains] P2, n = 4; P5, n = 4; P7, n = 4; P10, n = 4; P21, n = 4
Fig 1f
MGE interneurons in 
upper/lower cortical layers 
(mean ± SEM)
Lower layers: P5:  460726 ± 8473 P7: 386796  ± 25084 P10: 
292980  ± 25344 P21: 311903  ± 1491
Upper Layers: P5:  262326 ± 19553 P7: 253188  ± 14999 P10: 
149582  ± 10093 P21: 154981  ± 13623
[brains] P5, n = 3; P7, n = 3; P10, n = 3; P21, n = 3 Two way ANOVA, (Age and Layer), Tukey's test
Lower layers: P5 vs P7,  p =0.0300 
(*); P7 vs P10, p =0.0055 (**);
Upper layers: ; P7 vs P10, p = 
0.0024 (**)
FIGURE  2 Measurement Values N Statistical P value
Fig2b MGE interneurons in LII/III S1BF (mean ± SEM)
P5: 6.493 ±  0.659; P7: 5.758 ± 0.2151;P8: 4.053 ±0.1972; P9 
4.124 ± 0.4422; P21: 3685 ± 0.0445 [brains] n=3 for all ages
One-way ANOVA with 
Tukey's test
P5 vs P8, p = 0.0072 (**), P5 vs P9, 
p =0.0088 (**), P5 vs P10, p 
=0.0027 (**), P7 vs P10, p =0.0204 
(*)
Fig2e
Calcium events 
(events/min) at P7 in cells 
that die at P8 vs. cells that 
live past P9
Cells that dies at P8 (median = 0.43, inter-quartile range = 0.67, 
mean = 0.65); Cells that live past P8 (median = 0.96, inter-quartile 
range = 1.1, mean = 1.0)
[cells] Cells that dies = 18; Cells that live= 153 cells, n = 3 pups Mann-Whitney test p = 0.027 (*)
Fig2f
ROC analysis of P7 event 
rate in discriminating 
between cells that die at P8 
vs. cells that live past P9 
Area under curve = 0.65 [cells] Cells that dies = 18; Cells that live= 153 cells, n = 3 pups Permutation test (Shuffled cell labels) p  = 0.025 (*)
FIGURE  3 Measurement Values N Statistical P value
hM3DQ PV -CNO: 176.79 ± 8.02; +CNO: 233.95 ± 5.81, [brains] hM3Dq-CNO, n=7; hM3Dq+CNO, n=6 2-tailed unpaired Student's t-test p  = 0.0002 (***)
hM3DQ SST hm3Dq-CNO: 129.91 ± 5.40; hM3Dq+CNO: 158.15 ± 
9.62 [brains] hM3Dq-CNO, n=9; hM3Dq+CNO, n=7
2-tailed unpaired 
Student's t-test p  = 0.0034 (**)
hM4DI PV hM4Di–CNO: 190.68 ± 3.65; hM4Di+CNO 147.61 ± 
12.34 [brains]  hM4Di-CNO: n=7; hM4Di+ CNO: n=5 
2-tailed unpaired 
Student's t-test p  = 0.0061 (**)
hM4DI SST hM4Di–CNO: 134.67 ± 5.02; hM4Di+CNO 111.86 ± 
5.34 [brains]  hM4Di-CNO: n=7; hM4Di+ CNO: n=5
2-tailed unpaired 
Student's t-test p  = 0.0044 (**)
FIGURE  4 Measurement Values N Statistical P value
NexCre PV Control : 209.7 ± 9.48; NexCre Bak Bax: 269.09 ± 
4.46; [brains] Control NexCre, n = 5; NexCre Bak Bax, n = 4; 
2-tailed unpaired 
Student's t-test p  = 0.0013 (**)
NexCre SST Control NexCre: 127.89 ± 3.72; NexCre Bak Bax: 
163.47 ± 4.08; [brains] n=5
2-tailed unpaired 
Student's t-test p  = 0.0002 (***)
NkxCre PV  Control NkxCre: 168.83 ±15.21; Nkx Cre Bak Bax: 
222.20 ±8.75 [brains] n=5
2-tailed unpaired 
Student's t-test p  = 0.0453 (*)
NkxCre SST  Control NkxCre: 119.70 ± 2.28; NkxCre Bak Bax: 
150.80 ± 3.11 [brains] n=5
2-tailed unpaired 
Student's t-test p < 0.0001 (***)
FIGURE  5 Measurement Values N Statistical P value
Fig 5a
Western blot for P-Akt/Akt --- 
levels were normalised to 
P5 in each experiment 
(mean ± SEM )
P5: 1 ± 0; P6:1.379 ± 0.1405; P7:1.986 ± 0.121; P8: 1.602 ± 0.122; 
P9: 1.835 ± 0.181; P10: 1.386 ± 0.159 [brains] n = 6
Friedman's test with 
Dunn's test
p = 0.0002 (***)                                  
P5 vs P7: p < 0.0001 (***); P5 vs P8 
p = 0.0214 (*); P5 vs P9 p = 0.003 
(**)
Fig 5d
PTEN mean intensity under 
tdTomato mask (mean ± 
SEM)
P5: 0.1039 ± 0.0060; P7: 0.1646 ± 0.0083; P8: 0.2288 ± 0.0050; 
P10: 0.1674 ± 0.0037
[cells] n = 223 for P5, n=184 for P7, n = 394 for P8, n = 395 for P10;    
[brains] n=3 for all ages
Kruskal-Wallis test with 
Dunn's test
P5 vs P7, p < 0.001 (***); P8 vs P10 
p < 0.001 (***)
Fig 5g PV, SST+ cell density (mean ± SEM)
PV Control Lhx6+/+: 121.9 ± 6.228; Lhx6Cre/+: 158.4 ± 1.1316             
SST Control Lhx6+/+: 154.58 ± 5.395; Lhx6Cre/+: 76.32 ± 5.173        [brains] Control Lhx6Cre, n=4; Lhx6Cre n=3
2-tailed unpaired 
Student's t-test
PV: p  = 0.0045 (**);                      
SST: p  = 0.0372 (*)
Fig 5j
PTEN integrated intensity 
under GABA mask 
normalised to mean vehicle 
intensity  (mean ± SEM)
Vehicle: 1 ±0.0284; CNO: 0.6537 ± 0.0145 [cells] n=1191 for vehicle; n=3231 for CNO; n=4 vehicle treated and n=8 CNO treated animals, 2 independent experiments
Kolmogorov Smirnov 
test  p < 0.001 (***)
FIGURE  S1 Measurement Values N P value
Cleaved caspase-3 and 
Nex+ cell density (mean ± 
SEM)
P2: 2.272 ± 0.2758; P4: 6.067 ± 0.3868; P6 : 0.9863 ± 0.2422 [brains] n = 3 One-way ANOVA with Tukey's test
F=0.1078, p = 0.8995.                      
P2 vs P4, p  = 0.0003 (***); P2 vs 
P7, p  = 0.0577, P4 vs P7, p < 
0.0001 (***)
Cleaved caspase-3 and 
Nkx2.1+ cell density (mean 
± SEM)
P5: 1.985 ± 0.3288; P7: 3.899 ± 0.4963; P10 : 0.8146 ± 0.2755 [brains] n = 3 One-way ANOVA with Tukey's test
F=16.91, p = 0.0034.                        
P5 vs P7, p  = 0.0272 (*); P7 vs P10, 
p  = 0.0029 (**); P5 vs P10, p  = 
0.1525
Fig S1d
Pyramidal neurons in 
whole cortex without 
subplate(mean ± SEM)
P2: 3746227 ± 12820.448; P3: 3589390.5  ± 76796.7315; P4: 
3394496  ± 98193.9361; P5: 3275600.23  ± 76762.6195; P21: 
3296285.5  ± 107805.748
[brains] P2, n = 3; P3, n = 4; P4, n = 4; P5, n = 3; P21, n = 4 One-way ANOVA with Tukey's test
P2 vs P5,  p  = 0.0291(*); P2 vs P21, 
p  = 0.0254 (*)
Fig S1e
Percentage change of 
pyramidal neuron and MGE  
interneurons (mean ± SEM)
P2: 0 ± 3.20; P3: 4.18 ± 2.05; P4: 9.39 ± 2.62; P5: 12.56 ± 2.05; 
P21: 12.01 ± 2.88 [brains] P2, n = 3; P3, n = 4; P4, n = 4; P5, n = 3; P21, n = 4
FIGURE  S2 Measurement Values N Statistical P value
Fig S2b MGE interneurons in  S1BF (mean ± SEM)
P5: 22213 ± 1301; P7: 21897  ± 788.2; P8: 19212  ± 755.6; P9: 
18181 ± 279.8; P10: 17671  ± 707.3 [brains] P5, n=3; P7, n=3; P8, n=3; P9, n=3; P10, n=3
One-way ANOVA with 
Dunnett's test
P7 vs P9, p = 0.0323 (*); P7 vs P10, 
p = 0.0160 (*)
FIGURE  S3 Measurement Values N Statistical P value
Fig S3b GABA+, NeuN+/GABA- cell density (mean ± SEM)
GABA: hM3Dq - CNO: 195.5 ± 10.48; hM3Dq +CNO: 257.6 ± 
3.851         
NeuN+/GABA-: hM3Dq - CNO: 864.7 ± 63.09; hM3Dq +CNO: 
902.3 ± 49.64         
[brains] hM3Dq-CNO, n=4; hM3Dq+CNO, n=3; 2-tailed unpaired Student's t-test
GABA: p  = 0.0047 (**)
NeuN+/GABA-: p  = 0.6781
PV+ cell density  % (mean 
± SEM)
hM3Dq - CNO: 0 [I]; 24.71% ± 1.8 [II/III]; 25.95% ± 1.39[IV]; 31.98 ± 
0.96 [V]; 17.35 ± 0.65 [ VI];                                                       hM3Dq 
+CNO: 0[I]; 23.07 ± 1.33 [II/III]; 26.15 ± 1.25 [IV]; 33.47 ± 0.19 [V]; 
17.31 ± 0.88[VI]
[brains] hM3Dq-CNO, n=7; hM3Dq+CNO, n=6; 
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 11) = 0.483, p  = 0.5015
SST+ cell density  % (mean 
± SEM)
hM3Dq - CNO: 1.18 ± 0.20 [I]; 19.97% ± 0.77 [II/III]; 13.38% ± 
0.45[IV]; 42.87 ± 0.54 [V]; 22.60 ± 0.74 [ VI];                                                              
hM3Dq +CNO: 1.42 ± 0.21 [I]; 19.36 ± 0.61 [II/III]; 14.09 ± 0.48 [IV]; 
43.66 ± 0.79 [V]; 21.48 ± 0.51[VI]
[brains] hM3Dq-CNO, n=9; hM3Dq+CNO, n=7; 
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 14) = -0.04405, p  > 0.9999
PV+ cell density  % (mean 
± SEM)
hM4DI - CNO: 0 [I]; 22.88% ± 1.16 [II/III]; 23.33% ± 1.09[IV]; 33.67 ± 
0.77 [V]; 19.5 ± 0.32 [ VI];                                                               hM4Di 
+CNO: 0[I]; 21.45 ± 0.59 [II/III]; 25.404 ± 0.58 [IV]; 33.67 ± 0.78 [V]; 
19.5 ± 0.32[VI]
[brains] hM4Di-CNO: n=7; hM4Di+ CNO: n=5,
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 10) = 0.8772, p  = 0.3710
SST+ cell density  % (mean 
± SEM)
hM4DI - CNO: 1.51±0.22 [I]; 17.71% ± 0.60 [II/III]; 12.57% ± 
9.45[IV]; 46.58 ± 0.80 [V]; 21.62 ± 0.68 [VI];                                            
hM4Di +CNO: 1.16 ± 0.21 [I]; 18.08 ± 0.78 [II/III]; 13.65 ± 0.39 [IV]; 
44.84 ± 1.18 [V]; 22.26 ± 1.38[VI]
[brains] hM4Di-CNO: n=7; hM4Di+ CNO: n=5; 
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 10) = 0.7948, p = 0.3936
PV+ cell density (mean ± 
SEM) –CNO :  146.8 ± 7.233, + CNO : 140. 8725 ± 8.725 [brains] n = 4
2-tailed unpaired 
Student's t-test p = 0.5702
SST+ cell density (mean ± 
SEM) –CNO : 99.39 ± 4.178, + CNO : 95.27 ± 3.097 [brains] n = 3
2-tailed unpaired 
Student's t-test p = 0.4719
FIGURE  S4 Measurement Values N Statistical P value
Fig S4c Cleaved caspase-3 cell density (mean ± SEM) hm3Dq-CNO: 3.053 ± 0.2388; hM3Dq+CNO: 4.46 ± 0.2214 [brains] hM3Dq-CNO, n=8; hM3Dq +CNO: n=7
2-tailed unpaired 
Student's t-test p = 0.0009 (***)
PV+ cell density (mean ± 
SEM)
hm3Dq-CNO: 176.79 ± 8.02; hM4Di–CNO: 190.68 ± 3.65; 
uninjected CNO 195.41 ± 9.42 [brains] hM3Dq-CNO, n=7;  hM4Di-CNO: n=7; uninjected CNO: n=4, 
One-way ANOVA with 
Tukey's test F=1.551, p = 0.2441
SST+ cell density (mean ± 
SEM)
hm3Dq-CNO: 129.91 ± 5.40; hM4Di–CNO: 134.67 ± 5.02; 
uninjected 128.15 ± 4.22 [brains] hM3Dq-CNO, n=9; hM4Di-CNO: n=7; uninjected CNO: n=4, 
One-way ANOVA with 
Tukey's test F=0.4394, p = 0.6515
FIGURE  S5 Measurement Values N Statistical P value
hM3DQ PV -CNO: 171.01 ± 6.65; +CNO: 172.33 ± 8.13, [brains] hM3Dq-CNO, n=4; hM3Dq+CNO, n=3 2-tailed unpaired Student's t-test p = 0.904
hM4Di PV –CNO: 193.95 ± 7.56; +CNO 167.82 ± 8.87 [brains] n = 3 2-tailed unpaired Student's t-test p = 0.0873
Table S1. Summary of data and statistical analyses, related to Figures 1, 2, 3, 4, 5, S1, S2, S3, S4, S5, S6, S7, S8, S9
PV and SST+ cell density 
(mean ± SEM)Fig 3d
Fig 4c PV and SST+ cell density (mean ± SEM)
Fig S5d PV+ cell density (mean ± SEM)
Fig S3c
Fig S3f
Fig S4e
Fig S3d
Fig S1b 
Fig S5e PV+ cell density  % (mean ± SEM)
hM3Dq - CNO: 0 [I]; 22.67% ± 0.7 [II/III]; 28.8% ± 0.33[IV]; 31.62 ± 
0.86 [V]; 16.91 ± 0.55 [ VI];
hM3Dq +CNO: 0[I]; 21.44 ± 1.43 [II/III]; 30.33 ± 0.60 [IV]; 33.51 ± 
1.53 [V]; 14.71 ± 1.16[VI]
[brains] hM3Dq-CNO, n=4; hM3Dq+CNO, n=3
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 5) = 0.1499, p  =0.7146
Fig S5f PV+ cell density  % (mean ± SEM)
hM4DI - CNO: 0 [I]; 23.67% ± 0.24 [II/III]; 26.65% ± 1.14[IV]; 33.74 ± 
0.85 [V]; 15.96 ± 0.90 [ VI];
hM4Di +CNO: 0[I]; 21.22 ± 1.4 [II/III]; 28.09 ± 0.45 [IV]; 35.11 ± 2.5 
1V]; 15.58 ± 1.53[VI]
[brains] n = 3
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 4) = 0.9997, p  =0.3740
hm3Dq SST -CNO: 137.74 ± 2.94; +CNO: 134.56 ± 4.50 [brains] hM3Dq-CNO, n=4; hM3Dq+CNO, n=3 2-tailed unpaired Student's t-test p = 0.5627
hM4Di SST –CNO: 143.88 ± 5.16; +CNO 132.89 ± 9.51 [brains] n = 3 2-tailed unpaired Student's t-test p = 0.3672
Fig S5h SST+ cell density  % (mean ± SEM)
hM3Dq - CNO: 0.96 ± 0.26 [I]; 16.37% ± 1.21 [II/III]; 14.26% ± 
0.95[IV]; 47.44 ± 1.28 [V]; 20.98 ± 1.13 [ VI];
hM3Dq +CNO: 0.67 ± 0.12 [I]; 15.88 ± 1.34 [II/III]; 14.18 ± 0.86 [IV]; 
47.88 ± 0.85 [V]; 21.39 ± 1.64[VI]
[brains] hM3Dq-CNO, n=4; hM3Dq+CNO, n=3
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 5) = 0.5955, p  =0.4752
Fig S5i SST+ cell density  % (mean ± SEM)
hM4DI - CNO: 1.12 ± 0.17 [I]; 15.91% ± 0.53 [II/III]; 13.21% ± 
0.39[IV]; 47.4 ± 1.07 [V]; 22.36 ± 1.03 [ VI];
hM4Di +CNO: 0.73 ± 0.2[I]; 15.3± 1.44 [II/III]; 13.11 ± 0.67 [IV]; 
49.69 ± 0.96 [1V]; 21.17 ± 2.86[VI]
[brains] n = 3
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 4) = 1.78, p  =0.2531
FIGURE  S6 Measurement Values N Statistical P value
Fig S6b Pyramidal neurons in whole cortex (mean ± SEM) P2: 4175154.67 ± 148961.82; P21: 4360600 ± 38905.64 [brains] n = 3 
2-tailed unpaired 
Student's t-test p  = 0.30
FIGURE  S7 Measurement Values N Statistical P value
PV+ cell density (mean ± 
SEM)
Control NexCre 0 [1] 22.17% ± 0.98[II/III]; 24.19 ± 1.44[IV]; 34.32 ± 
1.51[V]; 19.32 ±0.67[VI];                                                           NexCre 
Bak Bax: 0[I]; 22.86 ± 0.51[II/III] ;26.89 ± 1.17 [IV]; 34.23 ± 0.75 [V]; 
16.82 ± 0.43[VI]
[brains] Control NexCre, n = 5; NexCre Bak Bax, n = 4; 
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 7) = 3.559, p  = 0.1012
SST+ cell density (mean ± 
SEM)
Control NexCre 1.73 ± 0.44 [1] 17.79% ± 1.21[II/III]; 12.05 ± 0.82 
[IV]; 42.73 ± 1.02 [V];25.71  ±1.17[VI];                                                     
NexCre Bak Bax: 0.92 ± 0.14[I]; 19.26% ± 0.71[II/III]; 12.28 ± 0.78 
[IV]; 43.19 ± 0.29 [V]; 24.36 ± 0.78[VI]
[brains] Control NexCre, n = 5; NexCre Bak Bax, n = 5; 
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 8) = 0.4366, p  = 0.5273
PV+ cell density (mean ± 
SEM)
Control NkxCre 0 [1] 22.75% ± 1.39[II/III]; 23.17 ± 1.20[IV]; 35.77 ± 
0.84[V]; 18.30 ±0.91[VI] ;                                                              
NkxCre Bak Bax: 0[I]; 25.32 ± 1.24[II/III] ;24.91 ± 1.51[IV]; 32.32 ± 
0.89 [V]; 17.45 ± 0.86[VI]
[brains] n = 5
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 8) = 0, p  > 0.9999
SST+ cell density (mean ± 
SEM)
Control NkxCre 1.12 ± 0.19 [1] 16.48% ± 1.23[II/III]; 16.17 ± 1.05 
[IV]; 42.75 ± 1.45 [V];23.59  ±0.88[VI] ;                                       
NkxCre Bak Bax: 0.81 ± 0.07[I]; 18.58% ± 1.423[II/III]; 15.95 ± 
1.10 [IV]; 40.24 ± 1.92 [V]; 24.45 ± 0.55[VI]
[brains] n = 5
Two-way ANOVA, (Cell 
density ~ 
Treatment*Layers) with 
Sidak's test
F (1, 8) = 0.4366, p  = 0.5273
Fold change compared to 
control (PV)
NexCre  Bak Bax : 1.276 ± 0.02116, NkxCre Bak Bax : 1.29 ± 
0.08187 [brains]  NexCre Bak Bax, n = 4; NkxCre Bak Bax, n=6
2-tailed unpaired 
Student's t-test p  = 0.902
Fold change compared to 
control (SST)
NexCre Bak Bax : 1.278 ± 0.03192, NkxCre Bak Bax: 1.26 ± 
0.02595 [brains] n = 5
2-tailed unpaired 
Student's t-test p  = 0.665
PV+ cell density (mean ± 
SEM) Control NexCre, 125.2 ± 10.12 ; NexCre Bak Bax, 164.1 ± 6.881 [brains] Control NexCre, n = 3; NexCre Bak Bax, n = 4; 
2-tailed unpaired 
Student's t-test p  = 0.0201 (*)
SST+ cell density (mean ± 
SEM) Control NexCre, 75.36 ± 4.433; NexCre Bak Bax, 98.04 ± 3.367 [brains] Control NexCre, n = 3; NexCre Bak Bax, n = 4; 
2-tailed unpaired 
Student's t-test p  = 0.0171 (*)
FIGURE  S8 Measurement Values N Statistical P value
Fig S8b
PTEN mean intensity under 
tdTomato mask (mean ± 
SEM)
P5: 0.3535 ± 0.0072; P7: 0.2466 ± 0.0011; P8: 0.3157 ± 0.0009; 
P10: 0.168 ± 0.0008
[cells] n = 7270 for P5, n=4544 for P7, n = 6780 for P8, n = 5043 for P10;    
[brains] n=3 for all ages
Kruskal-Wallis test with 
Dunn's test
P5 vs P7, p  < 0.0001 (***); P8 vs 
P10 p  < 0.0001 (***)
GABA+, NeuN+/GABA- 
cell density (mean ± SEM)
GABA:Ptenfl/fl: 121 ± 11.66; Lhx6-Cre;Ptenfl/fl: 207.3 ± 7.632         
NeuN+/GABA-: Ptenfl/fl: 1094 ± 61.29; Lhx6-Cre;Ptenfl/fl: 1239 ± 
43.52  
[brains] n=3; 
GABA+:  2-tailed 
unpaired Student's t-test
NeuN+/GABA-: 
Kolmogorov-Smirnov 
test
GABA: p  = 0.0035 (**)
NeuN+/GABA-: p  = 0.1
Vessel area  (% mean ± 
SEM)
Vessel diameter (mean ± 
SEM)
Vessel area:Ptenfl/fl: 25.24 ± 0.7984; Lhx6-Cre;Ptenfl/fl: 30.47 ± 
1.807
Vessel diameter: Ptenfl/fl: 8.471 ± 0.2356; Lhx6-Cre;Ptenfl/fl: 
9.298 ± 0.3069
[brains] Ptenfl/fl, n=4; Lhx6-Cre;Ptenfl/fl n=3 2-tailed unpaired Student's t-test
Vessel area: p  = 0.0326 (*)
Vessel diameter: p  = 0.081
PV+ cell density  % (mean 
± SEM)
Ptenfl/fl  0 [I]; 11.43% ± 1.55 [II/III]; 31.8% ± 1.21 [IV]; 33.7% ± 2.25 
[V]; 17.89  ± 1.18 [VI];
Lhx6-Cre;Ptenfl/fl : 0.37%  ± 2.7 [I]; 13.8% ± 0.95 [II/III] ;31% ± 
2.99 [IV]; 32.74% ± 1.78 [V]; 14.95% ± 0.862 [VI]
[brains] Ptenfl/fl, n=4; Lhx6-Cre;Ptenfl/fl n=3
Two-way ANOVA, (Cell 
density ~ 
Genotype*Layers) with 
Sidak's test
F (1,5) =0.2942, p  = 0.6108
SST+ cell density (mean ± 
SEM)
Ptenfl/fl  2.193%  ± 0.72 [I]; 18.35% ± 2.17 [II/III]; 20.28% ± 0.815 
[IV]; 25.55% ± 1.28 [V]; 17.74  ± 3.23 [VI];  
Lhx6-Cre;Ptenfl/fl : 0.37%  ± 2.7 [I]; 13.8% ± 0.95 [II/III] ;31% ± 
2.99 [IV]; 32.74% ± 1.78 [V]; 14.95% ± 0.862 [VI]
[brains] Ptenfl/fl, n=4; Lhx6-Cre;Ptenfl/fl n=3
Two-way ANOVA, (Cell 
density ~ 
Genotype*Layers) with 
Sidak's test
F(1,5) =0.0004, p  = 0.9849
FIGURE  S9 Measurement Values N Statistical P value
Fig S9c
Vessel area  (% mean ± 
SEM)
Vessel diameter (mean ± 
SEM)
Vessel area:Vehicle: 27.15 ± 0.7851; BpV(pic): 25.92 ± 0.7108
Vessel diameter: Vehicle: 10.03 ± 0.9661; BpV (pic): 9.416 ± 
0.3157
[brains] n=3
Vessel area: 
Kolmogorov-Smirnov 
test
Vessel diameter:  2-
tailed unpaired 
Student's t-test
Vessel area: p  = 0.6000
Vessel diameter: p  = 0.5756
PV+ Cell density (mean ± 
SEM) Vehicle : 256.8 ± 10.1; BpV(pic) : 288.7 ± 9.007 [brains] n = 7
2-tailed unpaired 
Student's t-test p  = 0.0365 (*)
SST+ Cell density (mean ± 
SEM) Vehicle : 168.1 ± 4.87; BpV(pic) : 187.9 ± 6.72 [brains] n = 7
2-tailed unpaired 
Student's t-test p  = 0.0339 (*)
PV+ Cell density (mean ± 
SEM) Vehicle : 250.1± 7.049; BpV(pic) : 253 ± 12.12 [brains] n = 5
2-tailed unpaired 
Student's t-test p  = 0.84
SST+ Cell density (mean ± 
SEM) Vehicle : 154.8 ± 3.64; BpV(pic) : 155.9 ± 2.7 [brains] n = 5
2-tailed unpaired 
Student's t-test p  = 0.82
Fig S9h
Fig S9e
Fig S7d
Fig S7b
Fig S7a
Fig S8e 
Fig S8d
Fig S5g SST+ cell density (mean ± SEM)
